通腑汤对腹腔间隔室综合征肠黏膜屏障的干预作用
|
摘要
1研究背景和目的肠道不仅是一个吸收和消化的器官,同时在机体非特异性抗感染防御系统中起着重要作用。完整的肠黏膜屏障功能是肠道多种功能得以正常维持的基础。在创伤和感染等应激情况下,肠道的屏障功能受到削弱或损害,就可使大量细菌和内毒素经由门静脉和淋巴系统侵入体循环,造成肠源性感染(Gut origin sepsis)和内毒素血症(Endotoxemia,ETM),并在一定条件下激发细胞因子和其他炎性介质的连锁反应,引起全身各器官的损害。因此,胃肠道被认为是导致多器官功能障碍综合征(multiple organs dysfunction syndrome, MODS)的“动力部位”和靶器官。腹腔间隔室综合征(abdominal compartment syndrome, ACS)时腹腔压增高,肠系膜动脉、肝动脉、小肠黏膜、肝脏微循环及门静脉血流减少,造成肠黏膜和黏膜下组织无氧代谢、酸中毒和缺血再灌注损伤,肠黏膜屏障功能受损,引起细菌和内毒素易位。因此研究腹腔压变化规律和腹内高压对肠黏膜屏障的影响,探讨腹腔间隔室综合征状态下肠黏膜屏障的防护措施等相关问题具有重要意义。
通腑汤是导师李乃卿教授的经验方和北京中医药大学东直门医院院内制剂,临床应用已有30多年的历史。在治疗急性重症胰腺炎、胃大部切除术后肠蠕动迟缓、以及麻痹性肠梗阻等方面,能够改善患者腹胀、腹痛、促进肠鸣音恢复和排便排气。本研究在导师多年临床研究的基础上,采用现代中西医结合医学的研究方法,采用定量分析技术,对腹腔压变化的规律、腹腔压与血压变化的相关性、腹内对肠黏膜通透性的影响的病理生理改变进行初步探索;与谷氨酰胺相对照,研究了通腑汤对腹腔压的干预作用、对腹腔间隔室综合征肠黏膜通透性增高的干预作用、对肠系膜微循环的干预作用;并对消化道恶性肿瘤患者术后腹腔压变化以及通腑汤的临床疗效作了初步研究。
2方法
本课题从腹腔间隔室综合征发生的病理生理学基础、干预治疗和临床防治三个方面进行了一些研究。包括六个部分:第一部分,腹腔压变化规律的研究;第二部分,通腑汤对大鼠腹腔压变化的干预作用;第三部分,腹腔压变化对血压的影响;第四部分,通腑汤对腹腔间隔室综合征大鼠肠黏膜屏障功能的干预作用;第五部分,通腑汤对腹腔间隔室综合征大鼠肠系膜微循环的干预作用;第六部分,通腑汤对消化道肿瘤患者术后腹腔压变化的干预作用。
第一部分,以SD大鼠为研究对象,以氮气气腹法成功制作了腹腔压增高的模型。定时定量向大鼠腹腔内注入氮气。利用MP-100A-CE型生理监护仪即时监测腹腔压动态变化。取每组各时间点腹腔压的算数平均值,绘制腹腔压和氮气量的散点图,应用回归分析方法分析腹腔压升高和降低的氮气量与腹腔压的函数关系。第二部分,腹腔高压造
1 Background and Objective
Intestinal tract is not only an organ of absorptive and digestive, but also an important organ in the non-specificity anti-infection system. Integrity of gut barrier is the foundation of the multiple function of intestinal tract to keep normal. When gut barrier is injured in the trauma and infection, plenty of bacteria and endotoxin intrude into general circulation trough portal vein and lymphatic system, and induced gut origin sepsis and endotoxemia, which will stimulate cascade reaction of cytokines and mediators of inflammation,making multiple organ suffered. Thus intestinal tract is regarded as motive power of multiple organ dysfunction syndrome. Intra-abdominal pressure increases in abdominal compartment syndrome patients. Blood flow of mesenteric artery, hepatic artery, mucous membrane of small intestine, microcirculation of liver and portal vein decreases. Intestinal mucous membrane and submucous tissue anaerobic metabolism, acidosis and ischemical reperfusion injury are occurred. Gut barrier is injured and causing bacteria and endotoxin translocation. Therefore studying the variation regularity of intra-abdominal pressure, the effect of abdominal compartment syndrome on the gut barrier, and investigating the protective method of gut barrier are important.
Tongfutang is an empirical formula of professor Li Naiqing and a preparation of Dongzimen Hospital of Beijing University of Chinese Medicine, which has been used for more than 30 years. In the treatment of acute sever pancreatitis, retardation of enterokinesia after subtotal gastrectomy and paralytic ileus, it can ameliorate abdominal distention, stomachache, promote bowel sound to recover,promote defecation and breaking wind. The investment based on professor Li’s long time clinical study of the preparation, adopting modern investment method of integrated Chinese and Western Medicine, using quantitative analysis technique, study the variation regularity of intra-abdominal pressure, the effect of intra-abdominal pressure on the blood pressure and intestinal mucosa permeability. Compared with glutamine, study the effect of Tongfutang on intra-abdominal pressure, the intervention in gut barrier dysfunction of abdominal compartment syndrome, and the influence on mesentery microcirculation. The effect of Tongfutang on intra-abdominal pressure of patients after alimentary tract malignant tumor surgery is observed clinically.
2 methods
The study investigate the pathologic physiology basis, treatment and clinical prevention
通腑汤是导师李乃卿教授的经验方和北京中医药大学东直门医院院内制剂,临床应用已有30多年的历史。在治疗急性重症胰腺炎、胃大部切除术后肠蠕动迟缓、以及麻痹性肠梗阻等方面,能够改善患者腹胀、腹痛、促进肠鸣音恢复和排便排气。本研究在导师多年临床研究的基础上,采用现代中西医结合医学的研究方法,采用定量分析技术,对腹腔压变化的规律、腹腔压与血压变化的相关性、腹内对肠黏膜通透性的影响的病理生理改变进行初步探索;与谷氨酰胺相对照,研究了通腑汤对腹腔压的干预作用、对腹腔间隔室综合征肠黏膜通透性增高的干预作用、对肠系膜微循环的干预作用;并对消化道恶性肿瘤患者术后腹腔压变化以及通腑汤的临床疗效作了初步研究。
2方法
本课题从腹腔间隔室综合征发生的病理生理学基础、干预治疗和临床防治三个方面进行了一些研究。包括六个部分:第一部分,腹腔压变化规律的研究;第二部分,通腑汤对大鼠腹腔压变化的干预作用;第三部分,腹腔压变化对血压的影响;第四部分,通腑汤对腹腔间隔室综合征大鼠肠黏膜屏障功能的干预作用;第五部分,通腑汤对腹腔间隔室综合征大鼠肠系膜微循环的干预作用;第六部分,通腑汤对消化道肿瘤患者术后腹腔压变化的干预作用。
第一部分,以SD大鼠为研究对象,以氮气气腹法成功制作了腹腔压增高的模型。定时定量向大鼠腹腔内注入氮气。利用MP-100A-CE型生理监护仪即时监测腹腔压动态变化。取每组各时间点腹腔压的算数平均值,绘制腹腔压和氮气量的散点图,应用回归分析方法分析腹腔压升高和降低的氮气量与腹腔压的函数关系。第二部分,腹腔高压造
1 Background and Objective
Intestinal tract is not only an organ of absorptive and digestive, but also an important organ in the non-specificity anti-infection system. Integrity of gut barrier is the foundation of the multiple function of intestinal tract to keep normal. When gut barrier is injured in the trauma and infection, plenty of bacteria and endotoxin intrude into general circulation trough portal vein and lymphatic system, and induced gut origin sepsis and endotoxemia, which will stimulate cascade reaction of cytokines and mediators of inflammation,making multiple organ suffered. Thus intestinal tract is regarded as motive power of multiple organ dysfunction syndrome. Intra-abdominal pressure increases in abdominal compartment syndrome patients. Blood flow of mesenteric artery, hepatic artery, mucous membrane of small intestine, microcirculation of liver and portal vein decreases. Intestinal mucous membrane and submucous tissue anaerobic metabolism, acidosis and ischemical reperfusion injury are occurred. Gut barrier is injured and causing bacteria and endotoxin translocation. Therefore studying the variation regularity of intra-abdominal pressure, the effect of abdominal compartment syndrome on the gut barrier, and investigating the protective method of gut barrier are important.
Tongfutang is an empirical formula of professor Li Naiqing and a preparation of Dongzimen Hospital of Beijing University of Chinese Medicine, which has been used for more than 30 years. In the treatment of acute sever pancreatitis, retardation of enterokinesia after subtotal gastrectomy and paralytic ileus, it can ameliorate abdominal distention, stomachache, promote bowel sound to recover,promote defecation and breaking wind. The investment based on professor Li’s long time clinical study of the preparation, adopting modern investment method of integrated Chinese and Western Medicine, using quantitative analysis technique, study the variation regularity of intra-abdominal pressure, the effect of intra-abdominal pressure on the blood pressure and intestinal mucosa permeability. Compared with glutamine, study the effect of Tongfutang on intra-abdominal pressure, the intervention in gut barrier dysfunction of abdominal compartment syndrome, and the influence on mesentery microcirculation. The effect of Tongfutang on intra-abdominal pressure of patients after alimentary tract malignant tumor surgery is observed clinically.
2 methods
The study investigate the pathologic physiology basis, treatment and clinical prevention
引文
1. 吴阶平,裘法祖,主编.黄家驷外科学.第 6 版.北京:人民卫生出版社.2000: 1065.
2. Magnotti LJ, Deitch EA. Burns, bacterial translocation, gut barrier function, and failure. J Burn Care Rehabil. 2005 Sep-Oct;26(5):383-91. Review.
3. 李乃卿.重新认识胃肠道,中华中西医临床杂志,2004,4(7):773-774.
4. Wilmore DW. The gut: a central organ after surgical stress. Surgery. 1988,104:917.
5. 黎介寿.肠衰竭-概念、营养支持与肠黏膜屏障维护. 肠外与肠内营养,2004,11(2):65-67.
6. Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin. 2005 Apr;21(2):177-96. Review.
7. Deitch EA, Xu D, Kaise VL. Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci. 2006 Jan 1;11:520-8.
8. 陈海龙,王辉.肠道屏障功能障碍.见李永渝,陈锡美,王志荣主编.实用消化系统病理生理学(M).第 1 版.上海:同济大学出版社,2003:52-65.
9. Liu Z, Li N, Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr. 2005 Apr;94(4):386-93.
10. Watson CJ, Hoare CJ, Garrod DR, et al. Interferon-gamma selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores.J Cell Sci. 2005 Nov 15;118(Pt 22):5221-30. Epub 2005 Oct 25.
11. Shen L, Turner JR. Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: tight junction dynamics exposed. Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G577-82.
12. Hase K, Ohno H.Epithelial cells as sentinels in mucosal immune barrier. Nihon Rinsho Meneki Gakkai Kaishi. 2006 Feb;29(1):16-26.
13. Chang JX, Chen S, Jiang LY, et al. Effect of goblet cell in rat intestine on the restitution process of the gut barrier after hemorrhagic shock. Zhonghua Wei Chang Wai Ke Za Zhi. 2005 Nov;8(6):510-2.
14. Isolauri E, Salminen S. Probiotics, gut inflammation and barrier function. Gastroenterol Clin North Am. 2005 Sep;34(3):437-50, viii. Review. No abstract available.
15. Ismail AS, Hooper LV. Epithelial cells and their neighbors. IV. Bacterial contributions to intestinal epithelial barrier integrity.Am J Physiol Gastrointest Liver Physiol. 2005 Nov;289(5):G779-84.
16. Verdu EF, Bercik P, Bergonzelli GE, et,al. Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology. 2004 Sep;127(3):826-37.
17. Llopis M, Antolin M, Guarner F, et al. Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid.Gut. 2005 Jul;54(7):955-9.
18. Husebye E.The pathogenesis of gastrointestinal bacterial overgrowth.Chemotherapy. 2005;51 Suppl 1:1-22.
19. Zareie M, Riff J, Donato K, et al. Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function.Cell Microbiol. 2005 Dec;7(12):1782-97.
20. 丁连安.肠屏障功能障碍. 肠外与肠内营养. 2005,12(1):55-58.
21. Kleessen B, Blaut M. Modulation of gut mucosal biofilms.Br J Nutr. 2005 Apr;93 Suppl 1:S35-40.
22. Yang R, Harada T, Li J, et al. Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism.Intensive Care Med. 2005 May;31(5):709-17.
23. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology. 2005Mar;41(3):422-33.
24. Review. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2005 Jan;17(1):27-31.
25. 王克勤,马恩陵,温 泉,等.肠道免疫屏障中上皮层内淋巴细胞的特点及影响因素.中国临床营养杂志,2003,11(1):51-56
26. Allez M, Mayer L. Regulatory T cells: peace keepers in the gut. Inflamm Bowel Dis. 2004 Sep; 10(5):666-76.
27. Demaude J, Salvador-Cartier C, Fioramonti J, et al. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut. 2006 May;55(5):655-61.
28. Thompson-Chagoyan OC, Maldonado J, et al. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.Clin Nutr. 2005 Jun;24(3):339-52.
29. Diebel LN, Liberati DM, Dulchavsky SA, et al. Enterocyte apoptosis and barrier function are modulated by SIgA after exposure to bacteria and hypoxia/reoxygenation.Surgery. 2003 Oct;134(4):574-80; discussion 580-1.
30. Galdeano CM, Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol. 2006 Feb;13(2):219-26.
31. Bollinger RR, Everett ML, Wahl SD, et al. Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili. Mol Immunol. 2006 Feb;43(4):378-87.
32. Assimakopoulos SF, Thomopoulos KC, Patsoukis N, Evidence for intestinal oxidative stress in patients with obstructive jaundice. Eur J Clin Invest. 2006 Mar;36(3):181-7.
33. Shi D, Das J, Das G. Inflammatory bowel disease requires the interplay between innate and adaptive immune signals.Cell Res. 2006 Jan;16(1):70-4.
34. Deitch EA, Forsythe R, Anjaria D, et al. The role of lymph factors in lung injury, bone marrow suppression, and endothelial cell dysfunction in a primate model of trauma-hemorrhagic shock.. Shock. 2004 Sep;22(3):221-8.
35. 史颖辉,李学荣,胡大海,等.硝酸镧块染法显示肠黏膜屏障通透性的电镜技术.11-12.
36. Johnston SD, Smye M, Watson RP. Intestinal permeability tests in celiac disease. Clin Lab. 2002,47(3-4):143-150.
37. Farhadi A, Keshavarzian A, Fields JZ, et al. Resolution of common dietary sugars from probe sugars for test of intestinal permeability using capillary column gas chromatography.J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Apr 16; [Epub ahead of print]
38. Paroni R, Fermo I, Molteni L, et al. Lactulose and mannitol intestinal permeability detected by capillary electrophoresis.J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Apr 13;834(1-2):183-7.
39. Piquet MA, Laurent D, Manceau S, et al.Increased intestinal permeability in patients with cirrhosis. Gastroenterology. 1997,112(suppl4):A1360.
40. Jiang ZM, CAO JD, Zhu XG, et al.The impact of alanyk-gluyamine on clinical safety,nitrogen balance,intestinal permeability,and clinical outcome in postoperative patients:a randomized ,double blind,controlled study of 120 patients. JPEN. 1999,23(5):S62-65.
41. 蒋朱明,于康.肠黏膜屏障损害与肠外和肠内营养.外科理论与实践.2000,5(l):54-58
42. Generoso M, De Rosa M, De Rosa R, et al. Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jan 15;783(2):349-57.
43. Marsilio R, D'Antiga L, Zancan L, et al. Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clin Chem. 1998 Aug;44(8 Pt 1):1685-91.
44. Liu H, Zhang S, Yu A, et al. Studies on intestinal permeability of cirrhotic patients by analysis lactulose and mannitol in urine with HPLC/RID/MS. Bioorg Med Chem Lett. 2004 May 3;14(9):2339-44.
45. Schietroma M, Carlei F, Cappelli S, et al. Intestinal permeability and systemic endotoxemia after laparotomic or laparoscopic cholecystectomy. Ann Surg. 2006 Mar;243(3):359-63.
46. Di Leo V, D'Inca R, Diaz-Granado N, et al. Lactulose/mannitol test has high efficacy for excluding organic causes of chronic diarrhea.Am J Gastroenterol. 2003 Oct;98(10):2245-52.
47. Sukkar SG, Schenone E, Foppiani L, et al. Experimental assessment of chemotherapy-induced early intestinal damage in colon cancer the lactulose-mannitol permeability test. Tumori. 2004 Sep-Oct;90(5):461-3.
48. 郑治钢.尿 L/M 比值在估测肠黏膜屏障功能中的价值. 中国中西医结合外科杂志,2000,6(6):435-436.
49. 黎君友,吕艺,付小兵,等.二胺氧化酶在创伤后肠道损伤中变化及意义.中国危重病急救医学2000,12(8)482-484.
50. Quan ZF, Yang C, Li N, et al. Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World J Gastroenterol. 2004 Jul 1;10(13):1992-4.
51. Wei YJ, Wang RL, Li GP. Influence on the concentration of plasma endotoxin by inhibition of complement activation in traumatic hemorrhagic shock rats Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Mar;18(3):180-3.
52. 陈秀凯,蒲践一,邱方,等.二胺氧化酶与 D-乳酸对脑损伤大鼠肠屏障功能的监测意义.中国煤炭工业医学杂志,2003,6(7): 669-671.
53. Li Z, Yang X, Lu L, et al. Gut barrier function damage following multiple firearm injuries in a porcine model.Chin Med Sci J. 2001 Dec;16(4):209-13.
54. Yang X, Li Z, Lu L, et al. An experiment of gut barrier function damage following multiple firearm injuries in a porcine model. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Oct;22(5):428-31.
55. Ruan P, Gong ZJ, Zhang QR. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin inpatients with liver cirrhosis. Hepatobiliary Pancreat Dis Int. 2004 Feb;3(1):58-61.
56. 吴承堂 , 黎沾良 . 二胺氧化酶在急性坏死性胰腺炎肠道损伤中的作用 . 世界华人消化杂志,1999;7(1):64-65.
57. 姚咏明,盛志勇,吴叶,等.大鼠急性肠缺血后 D-乳酸的变化及其与肠黏膜损害的关系[J].中华烧伤整形外科杂志,1998,4(4):266-269.
58. 孙晓庆,付小兵,张蓉,等.创伤后肠道通透性改变血浆标志物 D-乳酸的实验研究.中国危重病急救医学,2000,12(8)476-478.
59. Han X, Fink MP, Yang R, et al. Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice. Shock. 2004 Mar;21(3):261-70.
60. O'Brien DP, Nelson LA, Kemp CJ, et al. Intestinal permeability and bacterial translocation are uncoupled after small bowel resection.J Pediatr Surg. 2002 Mar;37(3):390-4.
61. Yang R, Harada T, Li J, et al. Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism. Intensive Care Med. 2005 May;31(5):709-17.
62. 彭曦,汪仕良,王斐,等.肠道营养支持对烧伤大鼠肠黏膜屏障功能的保护作用及其机理.基础医学与临床, 2001,21(4):352-355.
63. 常建星, 黄子通, 蒋龙元,等.肠屏障损伤后通透性与形态学改变的相关性研究.中国急救医学,2004,24(11):806-807.
64. Solligard E, Juel IS, Bakkelund K, et al. Gut barrier dysfunction as detected by intestinal luminal microdialysis. Intensive Care Med. 2004 Jun;30(6):1188-94. Epub 2004 Feb 28.
65. Gosain A, Gamelli RL. Role of the gastrointestinal tract in burn sepsis. J Burn Care Rehabil. 2005 Jan-Feb;26(1):85-91.
66. 赵 钢,江 伟,徐惠芳.大黄对肠缺血再灌注致大鼠炎症反应的防治作用. 南京铁道医学院学报2000;19(4):246-249.
67. Holland J, Carey M, Hughes N, et al. Intraoperative splanchnic hypoperfusion, increased intestinal permeability, down-regulation of monocyte class II major histocompatibility complex expression, exaggerated acute phase response, and sepsis. Am J Surg. 2005 Sep;190(3):393-400.
68. Deitch EA, Lu Q, Feketeova E,et al. Intestinal bacterial overgrowth induces the production of biologically active intestinal lymph. J Trauma. 2004 Jan;56(1):105-10.
69. Lozano FS, Barros MB, Fresnadillo MJ, et al. Nitric oxide prevents the bacterial translocation and inhibits the systemic inflammatory response produced by implantation of a vascular prosthesis followed by Zymosan A. Inflamm Res. 2005 Jun;54(6):261-70.
70. Solaroglu I, Okutan O, Kaptanoglu E, et al. Increased xanthine oxidase activity after traumatic brain injury in rats. J Clin Neurosci. 2005 Apr;12(3):273-5.
71. Lu BY, Chang JY. Assay of disulfide oxidase and isomerase based on the model of hirudin folding.Anal Biochem. 2005 Apr 1;339(1):94-103.
72. Odachi T, Koga S. Effects of long-term parenteral nutrition on gastrin release in dogs. Zentralbl Chir. 1987;112(13):863-8.
73. Alverdy J, Zaborina O, Wu L.The impact of stress and nutrition on bacterial-host interactions at theintestinal epithelial surface. Curr Opin Clin Nutr Metab Care. 2005 Mar;8(2):205-9. Review.
74. Davidson MT, Deitch EA, Lu Q, et al. A study of the biologic activity of trauma-hemorrhagic shock mesenteric lymph over time and the relative role of cytokines. Surgery. 2004 Jul;136(1):32-41.
75. Qin HL, Shen TY, Gao ZG, et al. Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection.World J Gastroenterol. 2005 May 7;11(17):2591-6.
76. Boikov SS, Moroz AF, Babaeva EE. Association of Candida albicans fungi with some opportunistic microorganisms in intestinal dysbiosis in patients of different age groups. Zh Mikrobiol Epidemiol Immunobiol. 2005 Mar-Apr;(2):65-9.
77. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut. 2001 Feb;48(2):198-205.
78. Homma H, Hoy E, Xu DZ, et al. The female intestine is more resistant than the male intestine to gut injury and inflammation when subjected to conditions associated with shock states.Am J Physiol Gastrointest Liver Physiol. 2005 Mar;288(3):G466-72.
79. Kasman LM. Barriers to coliphage infection of commensal intestinal flora of laboratory mice. Virol J. 2005 Apr 15;2:34.
80. Neal MD, Leaphart C, Levy R, et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol. 2006 Mar 1;176(5):3070-9.
81. Choda Y, Morimoto Y, Miyaso H, et al. Failure of the gut barrier system enhances liver injury in rats: protection of hepatocytes by gut-derived hepatocyte growth factor. Eur J Gastroenterol Hepatol. 2004 Oct;16(10):1017-25.
82. Schietroma M, Carlei F, Cappelli S,et,al. Intestinal permeability and systemic endotoxemia after laparotomic or laparoscopic cholecystectomy. Ann Surg. 2006 Mar;243(3):359-63.
83. 贾玉红,贾玉杰.内毒素血症与消化道疾病.见李永渝,陈锡美,王志荣主编.实用消化系统病理生理学(M).第 1 版.上海:同济大学出版社,2003:66-75.
84. Enomoto N, Takei Y, Yamashina S, et al. Burn injury sensitizes rat Kupffer cells via mechanisms dependent on gut-derived endotoxin.J Gastroenterol. 2004 Dec;39(12):1175-81.
85. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2005 Jan;17(1):45-51.
86. Qi W, Ebbert KV, Craig AW,et al. Absence of Fer protein tyrosine kinase exacerbates endotoxin induced intestinal epithelial barrier dysfunction in vivo. Gut. 2005 Aug;54(8):1091-7.
87. Pull SL, Doherty JM, Mills JC, et al. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury.Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):99-104.
88. Soderholm JD, Streutker C, Yang PC, et al. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.Gut. 2004 Dec;53(12):1817-24.
89. 曹建春,李乃卿.肠源性 MODS 研究现状.中华中西医临床杂志,2005,5(12):912-916.
90. Wang B, Glatzle J, Mueller MH, et al. Lipopolysaccharide-induced changes in mesenteric afferentsensitivity of rat jejunum in vitro: role of prostaglandins. Am J Physiol Gastrointest Liver Physiol. 2005 Aug;289(2):G254-60. Epub 2005 Mar 24.
91. Moriez R, Salvador-Cartier C, Theodorou V,et al. Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats.Am J Pathol. 2005 Oct;167(4):1071-9.
92. Schietroma M, Carlei F, Cappelli S,et al. Intestinal permeability and systemic endotoxemia after laparotomic or laparoscopic cholecystectomy. Ann Surg. 2006 Mar;243(3):359-63.
93. Stallion A, Kou TD, Latifi SQ, et al. Ischemia/reperfusion: a clinically relevant model of intestinal injury yielding systemic inflammation.J Pediatr Surg. 2005 Mar;40(3):470-7.
94. Horie Y, Han JY, Mori S, et al. Herbal cardiotonic pills prevent gut ischemia/reperfusion-induced hepatic microvascular dysfunction in rats fed ethanol chronically. World J Gastroenterol. 2005 Jan 28;11(4):511-5.
95. Chin J. Intestinal microflora: negotiating health outcomes with the warring community within us. Asia Pac J Clin Nutr. 2004;13(Suppl):S24-5.
96. Qin HL, Su ZD, Gao Q,et al. Early intrajejunal nutrition: bacterial translocation and gut barrier function of severe acute pancreatitis in dogs. Hepatobiliary Pancreat Dis Int. 2002 Feb;1(1):150-4.
97. Enomoto N, Takei Y, Yamashina S, et al. Burn injury sensitizes rat Kupffer cells via mechanisms dependent on gut-derived endotoxin.J Gastroenterol. 2004 Dec;39(12):1175-81.
98. Krack A, Sharma R, Figulla HR, et al. The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J. 2005 Nov;26(22):2368-74.
99. Krasnik L, Szponar B, Walczak M, et al. Routine clinical laboratory tests correspond to increased serum levels of 3-hydroxy fatty acids, markers of endotoxins, in cardiosurgery patients. Arch Immunol Ther Exp (Warsz).2006 Jan-Feb; 54(1): 55-60.
100. Ruhl A, Nasser Y,Sharkey KA.Enteric glia.Neurogastroenterol Motil. 2004,Apr;16 Suppl1:44-9.
101. Filos KS, Kirkilesis I, Spiliopoulou I, et al. Bacterial translocation, endotoxaemia and apoptosis following Pringle manoeuvre in rats. Injury. 2004 Jan;35(1):35-43.
102. Luyer MD, Buurman WA, Hadfoune M, et al. Pretreatment with high-fat enteral nutrition reduces endotoxin and tumor necrosis factor-alpha and preserves gut barrier function early after hemorrhagic shock. Shock. 2004 Jan;21(1):65-71.
103. Kennedy JA, Clements WD, Kirk SJ, et al. Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice. Br J Surg. 1999 May;86(5):628-33.
104. Wang YY, Dahle MK, Agren J, et al. Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation.Shock. 2006 Feb;25(2):141-6.
105. Yao HW, Yue L. Effect and mechanisms of FR167653, a dual inhibitor of TNF-alpha and IL-1, on BCG plus LPS induced-liver injury. Inflamm Res. 2005 Nov;54(11):471-7.
106. Enomoto N, Takei Y, Yamashina S, et al. Burn injury sensitizes rat Kupffer cells via mechanisms dependent on gut-derived endotoxin.J Gastroenterol. 2004 Dec;39(12):1175-81.
107. Miyaso H, Morimoto Y, Ozaki M, et al. Obstructive jaundice increases sensitivity tolipopolysaccharide via TLR4 upregulation: possible involvement in gut-derived hepatocyte growth factor-protection of hepatocytes. J Gastroenterol Hepatol. 2005 Dec;20(12):1859-66.
108. Giacometti A, Cirioni O, Ghiselli R, et al. Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. Gut. 2003 Jun;52(6):874-8.
109. Jonassen TE, Graebe M, Promeneur D, et al. Lipopolysaccharide-induced acute renal failure in conscious rats: effects of specific phosphodiesterase type 3 and 4 inhibition. J Pharmacol Exp Ther. 2002 Oct;303(1):364-74.
110. Cunha MA, Schor N. Effects of gentamicin, lipopolysaccharide, and contrast media on immortalized proximal tubular cells. Ren Fail. 2002 Nov;24(6):687-90.
111. Venkatesh B, Morgan TJ, Hall J,et al. Subcutaneous gas tensions closely track ileal mucosal gas tensions in a model of endotoxaemia without anaerobism. Intensive Care Med. 2005 Mar;31(3):447-53.
112. Diebel LN, Liberati DM, Baylor AE 3rd, et al. The pivotal role of tumor necrosis factor-alpha in signaling apoptosis in intestinal epithelial cells under shock conditions.J Trauma. 2005 May;58(5):995-1001.
113. 丁连安 黎介寿 李幼生,等.创伤及内毒素对大鼠肠屏障功能的损害 . 中华实验外科杂志,2004,2(6):697-699.
114. Kuru B, Dinc S, Altinok G, et al. Effect of different enteral nutrients on bacterial translocation in experimental obstructive jaundice. Eur Surg Res. 2004 Jan-Feb;36(1):45-52.
115. 彭 曦 , 汪 仕 良 , 尤 忠 义 , 等 . 肠 道 营 养 减 轻 严 重 烧 伤 所 致 肠 道 损 害 的 实 验 研 究 . 重 庆 医学,2002,(31)3:198-200.
116. 李元新, 李宁, 蒋小华,等.肠内营养对术后病人营养支持疗效的前瞻、随机、对照临床研究.肠外与肠内营养.2003,10(1):34-37.
117. 吴国豪.肠屏障功能障碍及防治对策.肠外与肠内营养, 2004,11(5): 313-316
118. Margaritis VG, Filos KS, Michalaki MA, et al. Effect of oral glutamine administration on bacterial tanslocation, endotoxemia, liver and ileal morphology, and apoptosis in rats with obstructive jaundice. World J Surg. 2005 Oct;29(10):1329-34.
119. Domeneghini C, Di Giancamillo A, Bosi G, et al. Can nutraceuticals affect the structure of intestinal mucosa? Qualitative and quantitative microanatomy in L-glutamine diet-supplemented weaning piglets.Vet Res Commun. 2006 Apr;30(3):331-42.
120. Coeffier M, Dechelotte P. The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome.Nutr Rev. 2005 Feb;63(2):65-9.
121. Hulsewe KW, van der Hulst RW, et al. Inflammation rather than nutritional depletion determines glutamine concentrations and intestinal permeability. Clin Nutr. 2004 Oct;23(5):1209-16.
122. Hulsewe KW, van Acker BA, Hameeteman W, et al. Does glutamine-enriched parenteral nutrition really affect intestinal morphology and gut permeability? Clin Nutr. 2004 Oct;23(5):1217-25.
123. Assimakopoulos SF, Vagianos CE, Zervoudakis G, et al. Gut regulatory peptides bombesin and neurotensin reduce hepatic oxidative stress and histological alterations in bile duct ligated rats. RegulPept. 2004 Aug 15;120(1-3):185-93.
124. Assimakopoulos SF, Scopa CD, Charonis A, et al. Experimental obstructive jaundice disrupts intestinal mucosal barrier by altering occludin expression: beneficial effect of bombesin and neurotensin. J Am Coll Surg. 2004 May;198(5):748-57.
125. Ding LA, Li JS, Li YS, et al. Prophylactic treatment with growth hormone improves intestinal barrier function and alleviates bacterial translocation in stressed rats. Chin Med J (Engl). 2004 Feb;117(2):264-9.
126. Feng J, El-Assal ON, Besner GE. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats.J Pediatr Surg. 2006 Jan;41(1):144-9; discussion 144-9.
127. Assimakopoulos SF, Alexandris IH, Scopa CD, et al. Effect of bombesin and neurotensin on gut barrier function in partially hepatectomized rats.World J Gastroenterol. 2005 Nov 21;11(43):6757-64.
128. Howe KL, Reardon C, Wang A, et al. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am J Pathol. 2005 Dec;167(6):1587-97.
129. 郑永波,吴承堂,黄祥成.L-精氨酸对严重腹腔感染大鼠肠屏障功能的影响. 中华急诊医学杂志2004,13(10):655-657.
130. Wischmeyer PE. Clinical applications of L-glutamine: past, present, and future. Nutr Clin Pract. 2003 Oct;18(5):377-85.
131. Tuohy KM,Rouzaud GC, Bruck WM, et al. Modulation of the human gut microflora towards improved health using prebiotics--assessment of efficacy. Curr Pharm Des. 2005;11(1):75-90.
132. Broekaert IJ, Walker WA. Probiotics as flourishing benefactors for the human body. Gastroenterol Nurs. 2006 Jan-Feb;29(1):26-34.
133. Brink M, Todorov SD, Martin JH, et al. The effect of prebiotics on production of antimicrobial compounds, resistance to growth at low pH and in the presence of bile, and adhesion of probiotic cells to intestinal mucus. J Appl Microbiol. 2006 Apr;100(4):813-20.
134. 邓群,黎沾良, 熊德鑫.选择性消化道灭菌对急性胰腺炎肠源性内毒素血症的预防作用. 中国外基础与临床杂志,2001, 8(6) : 361-363.
135. 陈海龙,刘艳,吴咸中,等.多器官功能不全综合征时肠道细菌易位及通里攻下法影响的实验研究. 中国微生态学杂志, 1998,10(6):342-346.
136. Kelly N, Friend K, Boyle P, et al. The role of the glutathione antioxidant system in gut barrier failure in a rodent model of experimental necrotizing enterocolitis. Surgery. 2004 Sep; 136(3):557-66.
137. Aw TY. Intestinal glutathione: determinant of mucosal peroxide transport, metabolism, and oxidative susceptibility. Toxicol Appl Pharmacol. 2005 May 1;204(3):320-8.
138. Koutelidakis I, Papaziogas B, Giamarellos-Bourboulis EJ, et al. Systemic endotoxaemia following obstructive jaundice: the role of lactulose. J Surg Res. 2003 Aug;113(2):243-7.
139. Zeissig S, Bojarski C, Buergel N, et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut. 2004Sep;53(9):1295-302. Erratum in: Gut. 2004 Nov;53(11):1722.
140. Malagon I, Onkenhout W, Klok M, et al. Dexamethasone reduces gut permeability in pediatric cardiac surgery.J Thorac Cardiovasc Surg. 2005 Aug;130(2):265-71.
141. 曹建春,张东萍,李乃卿.肠源性 MODS 的发生机制.医学研究杂志, 2006,35(2):56-57.
142. 张亚瑞,唐方. 中医药对肠屏障功能保护作用的研究概况.浙江中医杂志,2005,(3):133-135.
143. 刘蓉,唐方.中药保护肠屏障功能研究概况. 上海中医药杂志,2004, 38(12):57-59.
144. 张子理,陈蔚文.党参、黄芪、白术、甘草提取部位对小肠上皮细胞增殖的影响.中药药理与临床,2002,18(1):10-12.
145. 张 子 理 , 陈 蔚 文 . 黄 芪 注 射 液 和 白 术 提 取 部 位 对 小 肠 上 皮 细 胞 移 行 的 影 响 . 中 草药,2002,33(10):912-915.
146. 吴承堂,黎沾良.中药清胰汤对犬急性坏死性胰腺炎肠黏膜损伤修复的影响.中国普外基础与临床杂志,1998,5(6):326-328.
147. 姚永莉,宋于刚,张万岱.四君子汤治疗实验脾虚证对胃肠黏膜细胞增殖动力学的影响[J].世界华人消化杂志,1999,7(6):550.
148. 张建平,许利剑,徐凛峰,等.银杏叶提取物对大鼠实验性重症胰腺炎肠黏膜屏障功能的影响.江苏医药,2004,30(1): 18-20.
149. 王孟清,欧正武,吴明侦,等.健运冲剂促脾虚泄泻模型大鼠受损肠黏膜修复的研究[J].中国中西医结合脾胃杂志,1999,7(4):217-219.
150. 谢肄聪,唐方.藿香正气软胶囊对肠屏障功能保护作用的实验研究.中草药,2003,34(3):252-254.
151. 邱 奇,崔乃强,吴咸中.大承气冲剂对腹腔感染所致 SIRS/MODS 的治疗作用. 中国中西医结合外科杂志,2004, 10(4): 239-243.
152. 陈海龙,吴咸中,关凤林,等.中医攻里通下法对多脏器功能不全征时肠道屏障功能保护作用的实验研究.中国中西医结合杂志,2000,20(2):120.
153. 陈德昌,杨建东,景炳文,等.大黄对大鼠肠黏膜及肠血管通透性的影响. 中国危重病急救医学,1997,9(7):385-387.
154. 解基良,张志尧,吴咸中.承气方剂对肠屏障功能保护作用的实验研究. 中国中西医结合外科杂志.2002,8(3):189-191.
155. 倪孝儒,李雪蕾,曹建春.通腑汤高位直肠滴入治疗重症急性胰腺炎 46 例临床观察,中华中西医临床杂志,2004;4(7):814-815.
156. 邓轶,陈航,崔朝阳,等. 通腑汤保留灌肠治疗急性胰腺炎 45 例,北京中医药大学学报,2000,23:59-61
157. 孙欣,李乃卿.经肛肠途径营养支持的可行性探讨,中华中西医临床杂志,2003,3(6):683-689
158. 李乃卿.高位直肠滴入通腑汤的疗效观察。北京中医,1992,33(4):56-57.
159. 滕占庆,李乃卿。通腑汤调理胃肠道功能的疗效观察,中国中西医结合外科杂志,1997,3:102-104.
160. 倪孝儒,李乃卿,李雪蕾,等.通腑汤直肠高位滴注的临床研究,北京中医药大学学报,2000;23(2):61-63.
161. 黄棉生,刘东举,庄业忠,等.针刺保护胃肠道肿瘤术后 TPN 过程肠黏膜屏障损害的临床研究.中国肿瘤临床与康复,2002,9(1):40.
162. 康复笑,韩宜印,何淑贤,等.生大黄促进术后胃肠功能恢复的临床观察.中国中西医结合外科杂志,2002,8(3):168
163. 夏中元,罗涛,夏芳,等.生脉注射液对肠黏膜再灌注损伤保护作用机制的实验研究[J].中华麻醉学杂志,2001,21(5):299-301.
164. 陈少夫,贺丽,周卓,等.党参对兔胃十二指肠黏膜中胃泌素 生长抑素的影响[J].中国医科大学学报,2002,31(3):164-165.
165. 王 万 铁 , 徐 正 , 林 丽 娜 , 等 . 川 芎 嗪 对 肠 黏 膜 屏 障 功 能 的 保 护 作 用 . 中 国 病 理 生 理 杂 志 2001,17(9):882-885.
166. 黑子清,林世清,刘卫峰,等.黄茂对失血性休克再灌注兔肠黏膜微循环血流量的影响.中华麻醉学杂志,2003,23(7): 543-544.
167. 刘 承 哲 , 刘 牧 林 . 大 黄 对 多 器 官 衰 竭 大 鼠 肠 黏 膜 屏 障 的 保 护 作 用 [J]. 蚌 埠 医 学 院 学报,1998,23(6):380-381.
168. 黄兴兰,陈晓理,贾成瑶,等.大黄对 Balb/c 小鼠肠黏膜屏障保护作用的机理探讨[J].四川医学,1999,20(5):486-487.
169. 赵卫川,崔乃强,赵琪.承气合剂对缺血再灌流肠管内毒素转运的影响[J].中国中西医结合外科杂志,1998,4(2):83-86.
170. 陈海龙,冯立民,关凤林.阳明腑实证患者肠黏膜屏障功能的改变及复方大承气汤干预作用的临床观察[J].中医杂志,2003,44(9):672-673.
171. 李钢,陈海平,王凯成,等.中药合剂 AA3 保护实验性急性胰腺炎大鼠肠黏膜屏障的研究. 中国危重病急救医学,1999,11(5): 273-275.
172. 尤家平,蒋道国,李广元.芪连液保留灌肠治疗婴幼儿秋季腹泻临床与实验研究.中国中西医结合杂志,2000,20(9):664.
173. 张晓峰,苏佩清,任建素,等.中药清肠栓对溃疡性结肠炎大鼠实验模型的影响.河北医学,1998,4(5):1.
174. 次秀丽,王宝恩,张淑文,等.肿瘤坏死因子和内毒素致大鼠肠黏膜屏障损伤的中药治疗研究.中国危重病急救医学,1999,11(5):262.
175. 宋路线,徐迎新,宋旭华,等.大黄煎剂延迟并下调肠道相关淋巴细胞凋亡.实用医学杂志,2000,16(7):530.
176. 席军生,曹建春.肠源性 MODS. 中华实用中西医杂志,2005,18(23):1868-1869.
1. Cheatham ML. Intra-abdominal hypertension and abdominal compartment syndrome[J] .NewHorizons,1999,7(1):96～115.
2. Kron IL, Harman PK, Nolan SP. The measurement of intra-abdominal pressure as a criterion for abdominal re-exploration[J].Ann Surg,1984;199(1):28.
3. Hong JJ, Cohn SM, Perez JM, et al. Prospective study of the incidence and outcome of intra2abdominal hypertension and the abdominal compartment syndrome[J]. Br J Surg, 2002,89 (5):591-596.
4. 汤耀卿,雷若庆. 提高对重症急性胰腺炎合并腹腔间隔室综合征的认识. 外科理论与实践. 2001,6 (6) :361-362.
5. Malbrain ML, Deeren D, De Potter TJ.Intra-abdominal hypertension in the critically ill: it is time to pay attention. Curr Opin Crit Care. 2005 Apr;11(2):156-71.
6. Swan MC, Banwell PE. The open abdomen: aetiology, classification and current management strategies. J Wound Care. 2005 Jan;14(1):7-11.
7. Miller RS, Morris JA Jr, Diaz JJ Jr, et,al. Complications after 344 damage-control open celiotomies. J Trauma. 2005 Dec;59(6):1365-71; discussion 1371-4.
8. Espeel B, Gerard C, Nzamuche JR,et,al. Late abdominal compartment syndrome secondary to traumatic gallbladder rupture. Gastroenterol Clin Biol. 2005 Apr;29(4):453-5.
9. Lambert DM, Marceau S, Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg. 2005 Oct;15(9):1225-32.
10. Jensen AR, Hughes WB, Grewal H. Secondary Abdominal Compartment Syndrome in Children With Burns and Trauma: A Potentially Lethal Complication. J Burn Care Res. 2006 March/April;27(2):242-246.
11. Britt RC, Gannon T, Collins JN, et, al. Secondary abdominal compartment syndrome: risk factors and outcomes. Am Surg. 2005 Nov;71(11):982-5.
12. Hsu YP, Chen RJ, Fang JF, et,al. Increased susceptibility to oxidant injury in hepatocytes from rats with intra-abdominal hypertension. J Trauma. 2004 Sep;57(3):569-75.
13. Serpytis M, Ivaskevicius J. Intra-abdominal hypertension and multiple organ dysfunction syndrome. Medicina (Kaunas). 2005;41(11):903-9.
14. Shiiya N, Matsuzaki K, Miyatake T, et,al. Abdominal compartment syndrome causing respiratory failure during surgery for a ruptured descending thoracic aneurysm: report of a case. Surg Today. 2005;35(4):320-2.
15. Simon RJ, Friedlander MH,Ivatury RR,et al. Hemorrhage lower thethreshold for intra-abdominal hypertension(IAH) induced pulmonary dysfunction[J].J Trauma,1997;42(3):398
16. Stagnitti F, Calderale SM, Priore F, et,al. Abdominal compartment syndrome: patophysiologic and clinic remarks. G Chir. 2004 Oct;25(10):335-42.
17. Bloomfield GL,Blocher CR,Fakhry IF,et al. Elevated intra-abdominal pressure Increases plasma rennin activity and aldosterone levels[J].J Trauma,1997;42(6):997
18. Ma YM, Qian C, Xie F, et,al. Acute renal failure due to abdominal compartment syndrome. Zhonghua Yi Xue Za Zhi. 2005 Aug 17;85(31):2218-20.
19. de Jong IJ, Veeken H, van der Heide K, Clinical reasoning and decision-making in practice. A patientwith oliguria following prostatectomyNed Tijdschr Geneeskd. 2005 Dec 3;149(49):2720-7.
20. Diebel LN , Dulchavsky SA, Brown WJ. Splanchnic ischemia and bacterial translocation in the abdominal compartment syndrome[J]. J Trauma , 1997 ; 43 (5): 852
21. Bloomfield GL, Ridings PC, Blocher CR, et al. Aproposed relationship between increased intra-abdominal, intrathoracic, and intracranial pressure[J].Crit Care Med,1997;25(3):496
22. Bloomfield GL,Dalton JM,Sugerman HJ,et al.Treatment of increasing intracranial pressure secondary to the acute abdominal compartment syndrome in a patient with combined abdominal and head trauma[J].J Trauma,1995;39(6):1168
23. Pirson J, Zizi M, Jacob E, et,al. Acute ischemic optic neuropathy associated with an abdominal compartment syndrome in a burn patient. Burns. 2004 Aug;30(5):491-4.
24. Kutayli ZN, Domingo CB, Steinberg SM. Intestinal failure. Curr Opin Anaesthesiol. 2005 Apr;18(2):123-7.
25. Yagci G, Zeybek N, Kaymakcioglu N,et,al. Increased intra-abdominal pressure causes bacterial translocation in rabbits. J Chin Med Assoc. 2005 Apr;68(4):172-7.
26. 程君涛,肖光夏,夏培元,等.腹内高压对兔肠道通透性及内毒素细菌移位的影响.中华烧伤杂志2003,19(4):229-232.
27. Nast-Kolb D, Bail HJ, Taeger G.Current diagnostics for intra-abdominal trauma. Chirurg. 2005 Oct;76(10):919-26.
28. 李彤,许媛,毛羽. 腹腔室隔综合征的诊断与治疗. 腹部外科,2004,17(3):192-194.
29. Nagappan R, Ernest D, Whitfield A. Recognition and Management of Intra-abdominal Hypertension and Abdominal Compartment Syndrome. Crit Care Resusc. 2005 Dec;7(4):298-302.
30. Ertal W, Oberholzer A, Platz A, et al. Incidence and clinical pattern of the abdominal compartment syndrome after “damage-control”laparotomy in 311 patients with severe abdominal and/or pelvic trauma. Crit Care Med, 2000, 28: 1747-1753.
31. Burch JM, Moore EE, Moore FA, et al. The abdominal compartment syndrome. Surg Clin North Am,1996,76:833-842.
32. Maxwell RA, Fabian TC,Croce MA, et al.Secondary abdominal compartment syndrome: An under appreciated manifestation of severe hemorrhagic shock. J Trauma, 1999,47:995-999.
33. Ivy ME, Atweth NA,Palmer J, et al. Intra-abdominal hypertension and abdominal compartment syndrome in burn patients. J Trauma, 2000, 49: 387-391.
34. McNelis J, Marini CP, Jurkiewicz A, et al. Predictive factors associated with the development of abdominal compartment syndrome in the surgical intensive care unit. Arch Surg,2002,137:133-136.
35. Chen RJ , Fang JF , Chen MF. Intra-abdominal pressure monitoring as a guideline in the nonoperative management of blunt hepatic trauma [J]. J Trauma, 2001; 51 (1): 44.
36. Brooks AJ, Simpson A, Delbridge M, et,al. Validation of direct intraabdominal pressure measurement using a continuous indwelling compartment pressure monitor. J Trauma. 2005 Apr;58(4):830-2.
37. Kural T, Brabec M, Kuda J, The importance of measuring intraabdominal pressure in cases of severe acute pancreatitis. Zentralbl Chir. 2005 Apr;130(2):128-31.
38. Chan S, Doughan S. Intra-abdominal hypertension and the abdominal compartment syndrome . Br J Surg 2004; 91: 1102-1110.
39. Ravishankar N, Hunter J.Measurement of intra-abdominal pressure in intensive care units in the United Kingdom: a national postal questionnaire study. Br J Anaesth. 2005 Jun;94(6):763-6. Epub 2005 Mar 11.
40. Balogh Z, Jones F, D'Amours S, et,al. Continuous intra-abdominal pressure measurement technique. Am J Surg. 2004 Dec;188(6):679-84.
41. Pickhardt PJ,Shimony JS, Heiken JP, et al. The abdominal compartment syndrome: CT findings. Am J Roentgenol,1999,173:575-579.
42. Hobson KG, Young KM, CirauloA, et al. Release of abdominal compartment syndrome improves survival in patients with burn injury. J Trauma,2002,53:1129-1133.
43. Meldrum DR, Moore FA, Moore FF, et al. Prospective characterization and selective management of the abdominal compartment syndrome. Am J Surg, 1997,174:667-673
44. Bruch JM, Moore EE, Moore FA, et al. The abdominal compartment syndrome. Surg Clin North Am,1996;76:833-842.
45. Gallagher JJ. How to recognize and manage abdominal compartment syndrome. Nurs Manage. 2004;Suppl:36-42.
46. Flores-Alvarez E, Avila-Cuevas GE, de la Torre-Gonzalez JC, Early diagnosis and risk factors associated with abdominal compartment syndrome. Cir Cir. 2005 May-Jun; 73(3):179-83.
47. Stagnitti F, Calderale SM, Priore F, et al. Ribaldi S,Abdominal compartment syndrome: patophysiologic and clinic remarks. G Chir. 2004 Oct;25(10):335-42.
48. Gonullu D, Ceylan A, Demiray O, et, al. The effect of selective bowel decontamination and mechanical bowel preparation on bacterial translocation due to intraabdominal hypertension Ulus Travma Derg. 2005 Jul;11(3):201-5.
49. Balogh Z, Moore FA. Intra-abdominal hypertension: not just a surgical critical care curiosity. Crit Care Med. 2005 Feb;33(2):447-9.
50. Oda J, Ueyama M, Yamashita K, et, al. Hypertonic lactated saline resuscitation reduces the risk of abdominal compartment syndrome in severely burned patients. J Trauma. 2006 Jan;60(1):64-71.
51. O'Mara MS, Slater H, Goldfarb IW, et, al. A prospective, randomized evaluation of intra-abdominal pressures with crystalloid and colloid resuscitation in burn patients. J Trauma. 2005 May;58(5):1011-8.
52. 吴咸中.中西医结合急腹症方药诊释.天津:天津科学技术出版社,2001.356 -358.
53. 汤耀卿,雷若庆.提高对重症胰腺炎合并腹腔间隔室综合征的认识.外科理论与实践,2001,6(6):361- 362.
54. 何泽民.重症胰腺炎致急性腹腔间隔室综合征 21 例报告. 实用临床医学,2004,5(4):59-61
55. 李志新,邱锦芳,张忠.通腑攻下法治疗重症急性胰腺炎合并腹腔间隔室综合征临床体会. 新中医,2004,36(10):33-34.
56. Wong K, Summerhays CF. Abdominal compartment syndrome: a new indication for operativeintervention in severe acute pancreatitis. Int J Clin Pract. 2005 Dec;59(12):1479-81.
57. Moore EE. Staged laparotomy for the hypothermia, acidosis and coagulopathy syndrome. Am J Surg, 1997, 174:667-673.
58. Martinez-Ordaz JL, Cruz-Olivo PA, Chacon-Moya,et al. Management of the abdominal wall in sepsis. Comparison of two techniques. Rev Gastroenterol Mex. 2004 Apr-Jun;69(2):88-93.
59. De Waele JJ, Hoste EA, Malbrain ML.Decompressive laparotomy for abdominal compartment syndrome - a critical analysis. Crit Care. 2006 Mar 27;10(2):R51 [Epub ahead of print]
60. Kopelman T, Harris C, Miller R, et al. Abdominal compartment syndrome in patients with isolated extraperitoneal injuries. J Trauma, 2000; 49(4):744
61. Burrows R, Edington J, Robbs JV. A wolf in wolf’ s clothing: the abdominal compartment syndrome. S Afr Med J,1995;85(1):46
62. Oda J, Ueyama M, Yamashita K,et,al. Effects of escharotomy as abdominal decompression on cardiopulmonary function and visceral perfusion in abdominal compartment syndrome with burn patients. J Trauma. 2005 Aug;59(2):369-74.
63. Dakin GF, Nahouraii R, Gentileschi P, et,al. Subcutaneous endoscopic fasciotomy in a porcine model of abdominal compartment syndrome: a feasibility study. J Laparoendosc Adv Surg Tech A. 2004 Dec;14(6):339-44.
64. Hinck D, Struve R, Gatzka F,et,al. Vacuum-Assisted Fascial Closure in the Management of Diffuse Peritonitis. Zentralbl Chir. 2006 Apr;131(S 1):108-110.
65. Martinez-Ordaz JL, Cruz-Olivo PA, Chacon-Moya E, et,al. Management of the abdominal wall in sepsis. Comparison of two techniques. Rev Gastroenterol Mex. 2004 Apr-Jun;69(2):88-93.
66. Letoublon C, Cardin N, Arvieux C. Laparostomy with vacuum pack technique. Ann Chir. 2005 Oct;130(9):587-9. Epub 2005 Sep 27.
67. Kendrick JE 4th, Leath CA 3rd, Melton SM, et,al Use of a fascial prosthesis for management of abdominal compartment syndrome secondary to obstetric hemorrhage. Obstet Gynecol. 2006 Feb;107(2 Pt 2):493-6.
68. Offner PJ, de Souza AL, Moore EE, et al. Avoidance of abdominal compartment syndrome in damage-control laparotomy after trauma .Arch Surg,2001;136(6):676.
69. Saenko VF, Belianskii LS, Lisun IuB. Modern approaches to the problem of temporary closure of the abdominal cavity. Klin Khir. 2005 Mar;(3):5-11.
70. Hultman CS, Pratt B, Cairns BA,et,al. Multidisciplinary approach to abdominal wall reconstruction after decompressive laparotomy for abdominal compartment syndrome. Ann Plast Surg. 2005 Mar;54(3):269-75; discussion 275.
71. Hultman CS, Pratt B, Cairns BA, et al. Multidisciplinary Approach to Abdominal Wall Reconstruction After Decompressive Laparotomy for Abdominal Compartment Syndrome. Ann Plast Surg. 2005 Mar;54(3):269-275.
1. Britt RC, Gannon T, Collins JN, et, al. Secondary abdominal compartment syndrome: risk factors and outcomes. Am Surg. 2005 Nov;71(11):982-5.
2. Hsu YP, Chen RJ, Fang JF, et,al. Increased susceptibility to oxidant injury in hepatocytes from rats with intra-abdominal hypertension. J Trauma. 2004 Sep;57(3):569-75.
3. Serpytis M, Ivaskevicius J. Intra-abdominal hypertension and multiple organ dysfunction syndrome. Medicina (Kaunas). 2005;41(11):903-9.
4. Espeel B, Gerard C, Nzamuche JR,et,al. Late abdominal compartment syndrome secondary to traumatic gallbladder rupture. Gastroenterol Clin Biol. 2005 Apr;29(4):453-5.
5. 程君涛,肖光夏,夏培元,等.腹内高压对兔肠道通透性及内毒素细菌移位的影响.中华烧伤杂志2003,19(4):229-232.
6. Lambert DM, Marceau S, Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg. 2005 Oct;15(9):1225-32.
7. Jensen AR, Hughes WB, Grewal H. Secondary Abdominal Compartment Syndrome in Children WithBurns and Trauma: A Potentially Lethal Complication. J Burn Care Res. 2006 March/April;27(2):242-246.
8. Britt RC, Gannon T, Collins JN, et, al. Secondary abdominal compartment syndrome: risk factors and outcomes. Am Surg. 2005 Nov;71(11):982-5.
9. Hsu YP, Chen RJ, Fang JF, et,al. Increased susceptibility to oxidant injury in hepatocytes from rats with intra-abdominal hypertension. J Trauma. 2004 Sep;57(3):569-75.
10. Ravishankar N, Hunter J.Measurement of intra-abdominal pressure in intensive care units in the United Kingdom: a national postal questionnaire study. Br J Anaesth. 2005 Jun;94(6):763-6. Epub 2005 Mar 11.
11. Balogh Z, Jones F, D'Amours S, et,al. Continuous intra-abdominal pressure measurement technique. Am J Surg. 2004 Dec;188(6):679-84.
12. Pickhardt PJ,Shimony JS, Heiken JP, et al. The abdominal compartment syndrome: CT findings. Am J Roentgenol,1999,173:575-579.
13. Hobson KG, Young KM, CirauloA, et al. Release of abdominal compartment syndrome improves survival in patients with burn injury. J Trauma,2002,53:1129-1133.
14. Meldrum DR, Moore FA, Moore FF, et al. Prospective characterization and selective management of the abdominal compartment syndrome. Am J Surg, 1997,174:667-673
15. Bruch JM, Moore EE, Moore FA, et al. The abdominal compartment syndrome. Surg Clin North Am,1996;76:833-842.
16. Kendrick JE 4th, Leath CA 3rd, Melton SM, et,al Use of a fascial prosthesis for management of abdominal compartment syndrome secondary to obstetric hemorrhage. Obstet Gynecol. 2006 Feb;107(2 Pt 2):493-6.
17. Offner PJ, de Souza AL, Moore EE, et al. Avoidance of abdominal compartment syndrome in damage-control laparotomy after trauma [J].Arch Surg,2001;136(6):676.
18. Saenko VF, Belianskii LS, Lisun IuB. Modern approaches to the problem of temporary closure of the abdominal cavity. Klin Khir. 2005 Mar;(3):5-11.
19. Hultman CS, Pratt B, Cairns BA,et,al. Multidisciplinary approach to abdominal wall reconstruction after decompressive laparotomy for abdominal compartment syndrome. Ann Plast Surg. 2005 Mar;54(3):269-75; discussion 275.
20. Hultman CS, Pratt B, Cairns BA, et al. Multidisciplinary Approach to Abdominal Wall Reconstruction After Decompressive Laparotomy for Abdominal Compartment Syndrome. Ann Plast Surg. 2005 Mar;54(3):269-275.
21. 汤耀卿,雷若庆.提高对重症胰腺炎合并腹腔间隔室综合征的认识.外科理论与实践,2001,6(6):361- 362.
22. 何泽民.重症胰腺炎致急性腹腔间隔室综合征 21 例报告. 实用临床医学,2004,5(4):59-61
23. 李志新,邱锦芳,张忠.通腑攻下法治疗重症急性胰腺炎合并腹腔间隔室综合征临床体会. 新中医,2004,36(10):33-34.
1. Gallagher JJ. How to recognize and manage abdominal compartment syndrome. Nurs Manage. 2004;Suppl:36-42.
2. Flores-Alvarez E, Avila-Cuevas GE, de la Torre-Gonzalez JC, Early diagnosis and risk factors associated with abdominal compartment syndrome. Cir Cir. 2005 May-Jun; 73(3):179-83.
3. Meldrum DR, Moore FA, Moore FF, et al. Prospective characterization and selective management of the abdominal compartment syndrome. Am J Surg, 1997,174:667-673
4. Stagnitti F, Calderale SM, Priore F, et al. Ribaldi S,Abdominal compartment syndrome: patophysiologic and clinic remarks. G Chir. 2004 Oct;25(10):335-42.
5. Wong K, Summerhays CF. Abdominal compartment syndrome: a new indication for operative intervention in severe acute pancreatitis. Int J Clin Pract. 2005 Dec;59(12):1479-81.
6. Moore EE. Staged laparotomy for the hypothermia, acidosis and coagulopathy syndrome. Am J Surg, 1997, 174:667-673.
7. Martinez-Ordaz JL, Cruz-Olivo PA, Chacon-Moya,et al. Management of the abdominal wall in sepsis. Comparison of two techniques. Rev Gastroenterol Mex. 2004 Apr-Jun;69(2):88-93.
8. De Waele JJ, Hoste EA, Malbrain ML.Decompressive laparotomy for abdominal compartment syndrome - a critical analysis. Crit Care. 2006 Mar 27;10(2):R51 [Epub ahead of print]
9. Kopelman T, Harris C, Miller R, et al. Abdominal compartment syndrome in patients with isolated extraperitoneal injuries[J]. J Trauma, 2000; 49(4):744
10. Burrows R, Edington J, Robbs JV. A wolf in wolf’ s clothing: the abdominal compartment syndrome[J]. S Afr Med J,1995;85(1):46
11. Oda J, Ueyama M, Yamashita K,et,al. Effects of escharotomy as abdominal decompression on cardiopulmonary function and visceral perfusion in abdominal compartment syndrome with burn patients. J Trauma. 2005 Aug;59(2):369-74.
12. Chen RJ , Fang JF , Chen MF. Intra-abdominal pressure monitoring as a guideline in thenonoperative management of blunt hepatic trauma [J]. J Trauma, 2001; 51 (1): 44.
13. Dakin GF, Nahouraii R, Gentileschi P, et,al. Subcutaneous endoscopic fasciotomy in a porcine model of abdominal compartment syndrome: a feasibility study. J Laparoendosc Adv Surg Tech A. 2004 Dec;14(6):339-44.
14. Hinck D, Struve R, Gatzka F,et,al. Vacuum-Assisted Fascial Closure in the Management of Diffuse Peritonitis. Zentralbl Chir. 2006 Apr;131(S 1):108-110.
15. Martinez-Ordaz JL, Cruz-Olivo PA, Chacon-Moya E, et,al. Management of the abdominal wall in sepsis. Comparison of two techniques. Rev Gastroenterol Mex. 2004 Apr-Jun;69(2):88-93.
16. Letoublon C, Cardin N, Arvieux C. Laparostomy with vacuum pack technique. Ann Chir. 2005 Oct;130(9):587-9. Epub 2005 Sep 27.
17. Kendrick JE 4th, Leath CA 3rd, Melton SM, et,al Use of a fascial prosthesis for management of abdominal compartment syndrome secondary to obstetric hemorrhage. Obstet Gynecol. 2006 Feb;107(2 Pt 2):493-6.
18. Offner PJ, de Souza AL, Moore EE, et al. Avoidance of abdominal compartment syndrome in damage-control laparotomy after trauma [J].Arch Surg,2001;136(6):676.
19. Saenko VF, Belianskii LS, Lisun IuB. Modern approaches to the problem of temporary closure of the abdominal cavity. Klin Khir. 2005 Mar;(3):5-11.
20. Hultman CS, Pratt B, Cairns BA,et,al. Multidisciplinary approach to abdominal wall reconstruction after decompressive laparotomy for abdominal compartment syndrome. Ann Plast Surg. 2005 Mar;54(3):269-75; discussion 275.
21. Hultman CS, Pratt B, Cairns BA, et al. Multidisciplinary Approach to Abdominal Wall Reconstruction After Decompressive Laparotomy for Abdominal Compartment Syndrome. Ann Plast Surg. 2005 Mar;54(3):269-275.
22. Gonullu D, Ceylan A, Demiray O, et, al. The effect of selective bowel decontamination and mechanical bowel preparation on bacterial translocation due to intraabdominal hypertension Ulus Travma Derg. 2005 Jul;11(3):201-5.
23. Balogh Z, Moore FA. Intra-abdominal hypertension: not just a surgical critical care curiosity. Crit Care Med. 2005 Feb;33(2):447-9.
24. Oda J, Ueyama M, Yamashita K, et, al. Hypertonic lactated saline resuscitation reduces the risk of abdominal compartment syndrome in severely burned patients. J Trauma. 2006 Jan;60(1):64-71.
25. O'Mara MS, Slater H, Goldfarb IW, et, al. A prospective, randomized evaluation of intra-abdominal pressures with crystalloid and colloid resuscitation in burn patients. J Trauma. 2005 May;58(5):1011-8.
26. 吴咸中.中西医结合急腹症方药诊释.天津:天津科学技术出版社,2001.356 -358.
27. 汤耀卿,雷若庆.提高对重症胰腺炎合并腹腔间隔室综合征的认识.外科理论与实践,2001,6(6):361- 362.
28. 何泽民.重症胰腺炎致急性腹腔间隔室综合征 21 例报告. 实用临床医学,2004,5(4):59-61
29. 李志新,邱锦芳,张忠.通腑攻下法治疗重症急性胰腺炎合并腹腔间隔室综合征临床体会. 新中医,2004,36(10):33-34.
1. Hsu YP, Chen RJ, Fang JF, et,al. Increased susceptibility to oxidant injury in hepatocytes from rats with intra-abdominal hypertension. J Trauma. 2004 Sep;57(3):569-75.
2. Serpytis M, Ivaskevicius J. Intra-abdominal hypertension and multiple organ dysfunction syndrome. Medicina (Kaunas). 2005;41(11):903-9.
3. Shiiya N, Matsuzaki K, Miyatake T, et,al. Abdominal compartment syndrome causing respiratory failure during surgery for a ruptured descending thoracic aneurysm: report of a case. Surg Today. 2005;35(4):320-2.
4. Simon RJ, Friedlander MH,Ivatury RR,et al. Hemorrhage lower thethreshold for intra-abdominal hypertension(IAH) induced pulmonary dysfunction[J].J Trauma,1997;42(3):398
5. Stagnitti F, Calderale SM, Priore F, et,al. Abdominal compartment syndrome: patophysiologic and clinic remarks. G Chir. 2004 Oct;25(10):335-42.
6. Bloomfield GL,Blocher CR,Fakhry IF,et al. Elevated intra-abdominal pressure Increases plasma rennin activity and aldosterone levels[J].J Trauma,1997;42(6):997
7. Ma YM, Qian C, Xie F, et,al. Acute renal failure due to abdominal compartment syndrome. Zhonghua Yi Xue Za Zhi. 2005 Aug 17;85(31):2218-20.
8. de Jong IJ, Veeken H, van der Heide K, Clinical reasoning and decision-making in practice. A patient with oliguria following prostatectomyNed Tijdschr Geneeskd. 2005 Dec 3;149(49):2720-7.
9. Diebel LN , Dulchavsky SA, Brown WJ. Splanchnic ischemia and bacterial translocation in the abdominal compartment syndrome[J]. J Trauma , 1997 ; 43 (5): 852
10. Bloomfield GL, Ridings PC, Blocher CR, et al. Aproposed relationship between increasedintra-abdominal, intrathoracic, and intracranial pressure[J].Crit Care Med,1997;25(3):496
11. Bloomfield GL,Dalton JM,Sugerman HJ,et al.Treatment of increasing intracranial pressure secondary to the acute abdominal compartment syndrome in a patient with combined abdominal and head trauma[J].J Trauma,1995;39(6):1168
12. Pirson J, Zizi M, Jacob E, et,al. Acute ischemic optic neuropathy associated with an abdominal compartment syndrome in a burn patient. Burns. 2004 Aug;30(5):491-4.
13. Kutayli ZN, Domingo CB, Steinberg SM. Intestinal failure. Curr Opin Anaesthesiol. 2005 Apr;18(2):123-7.
14. Yagci G, Zeybek N, Kaymakcioglu N,et,al. Increased intra-abdominal pressure causes bacterial translocation in rabbits. J Chin Med Assoc. 2005 Apr;68(4):172-7.
15. 程君涛,肖光夏,夏培元,等.腹内高压对兔肠道通透性及内毒素细菌移位的影响.中华烧伤杂志2003,19(4):229-232.
1. 李乃卿.重新认识胃肠道,中华中西医临床杂志,2004,4(7):773-774.
2. Wilmore DW. The gut: a central organ after surgical stress. Surgery. 1988,104:917.
3. 黎介寿.肠衰竭-概念、营养支持与肠黏膜屏障维护. 肠外与肠内营养,2004,11(2):65-67.
4. Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin. 2005 Apr;21(2):177-96. Review.
5. Deitch EA, Xu D, Kaise VL. Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci. 2006 Jan 1;11:520-8.
6. 陈秀凯,蒲践一,邱方,等.二胺氧化酶与 D-乳酸对脑损伤大鼠肠屏障功能的监测意义.中国煤炭工业医学杂志,2003,6(7): 669-671.
7. 姚咏明,盛志勇,吴叶,等.大鼠急性肠缺血后 D-乳酸的变化及其与肠黏膜损害的关系[J].中华烧伤整形外科杂志,1998,4(4):266-269.
8. 孙晓庆,付小兵,张蓉,等.创伤后肠道通透性改变血浆标志物 D-乳酸的实验研究.中国危重病急救医学,2000,12(8)476-478.
9. 程君涛,肖光夏,夏培元,等.腹内高压对兔肠道通透性及内毒素细菌移位的影响.中华烧伤杂志,2003,19(4): 229-232
10. Margaritis VG, Filos KS, Michalaki MA, et al. Effect of oral glutamine administration on bacterial tanslocation, endotoxemia, liver and ileal morphology, and apoptosis in rats with obstructive jaundice. World J Surg. 2005 Oct;29(10):1329-34.
11. Domeneghini C, Di Giancamillo A, Bosi G, et al. Can nutraceuticals affect the structure of intestinal mucosa? Qualitative and quantitative microanatomy in L-glutamine diet-supplemented weaning piglets.Vet Res Commun. 2006 Apr;30(3):331-42.
12. Coeffier M, Dechelotte P. The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome.Nutr Rev. 2005 Feb;63(2):65-9.
13. Hulsewe KW, van der Hulst RW, et al. Inflammation rather than nutritional depletion determines glutamine concentrations and intestinal permeability. Clin Nutr. 2004 Oct;23(5):1209-16.
14. 曹建春,张东萍,李乃卿.肠源性 MODS 的发生机制.医学研究杂志, 2006,35(2):56-57.
15. 张亚瑞,唐方. 中医药对肠屏障功能保护作用的研究概况.浙江中医杂志,2005,(3):133-135.
16. 刘蓉,唐方.中药保护肠屏障功能研究概况. 上海中医药杂志,2004, 38(12):57-59.
17. 张子理,陈蔚文.党参、黄芪、白术、甘草提取部位对小肠上皮细胞增殖的影响.中药药理与临床,2002,18(1):10-12.
18. 张 子 理 , 陈 蔚 文 . 黄 芪 注 射 液 和 白 术 提 取 部 位 对 小 肠 上 皮 细 胞 移 行 的 影 响 . 中 草药,2002,33(10):912-915.
19. 吴承堂,黎沾良.中药清胰汤对犬急性坏死性胰腺炎肠黏膜损伤修复的影响.中国普外基础与临床杂志,1998,5(6):326-328.
20. 姚永莉,宋于刚,张万岱.四君子汤治疗实验脾虚证对胃肠黏膜细胞增殖动力学的影响[J].世界华人消化杂志,1999,7(6):550.
21. 张建平,许利剑,徐凛峰,等.银杏叶提取物对大鼠实验性重症胰腺炎肠黏膜屏障功能的影响.江苏医药,2004,30(1): 18-20.
22. 王孟清,欧正武,吴明侦,等.健运冲剂促脾虚泄泻模型大鼠受损肠黏膜修复的研究[J].中国中西医结合脾胃杂志,1999,7(4):217-219.
23. 谢肄聪,唐方.藿香正气软胶囊对肠屏障功能保护作用的实验研究.中草药,2003,34(3):252-254.
24. 邱 奇,崔乃强,吴咸中.大承气冲剂对腹腔感染所致 SIRS/MODS 的治疗作用. 中国中西医结合外科杂志,2004, 10(4): 239-243.
25. 陈海龙,吴咸中,关凤林,等.中医攻里通下法对多脏器功能不全征时肠道屏障功能保护作用的实验研究.中国中西医结合杂志,2000,20(2):120.
26. 陈德昌,杨建东,景炳文,等.大黄对大鼠肠黏膜及肠血管通透性的影响. 中国危重病急救医学,1997,9(7):385-387.
27. 解基良,张志尧,吴咸中.承气方剂对肠屏障功能保护作用的实验研究. 中国中西医结合外科杂志.2002,8(3):189-191.
28. 倪孝儒,李雪蕾,曹建春.通腑汤高位直肠滴入治疗重症急性胰腺炎 46 例临床观察,中华中西医临床杂志,2004;4(7):814-815.
29. 邓轶,陈航,崔朝阳,等. 通腑汤保留灌肠治疗急性胰腺炎 45 例,北京中医药大学学报,2000,
23:59-61
30. 孙欣,李乃卿.经肛肠途径营养支持的可行性探讨,中华中西医临床杂志,2003,3(6):683-
689
31. 李乃卿.高位直肠滴入通腑汤的疗效观察。北京中医,1992,33(4):56-57.
32. 滕占庆,李乃卿。通腑汤调理胃肠道功能的疗效观察,中国中西医结合外科杂志,1997,3:102-104.
33. 倪孝儒,李乃卿,李雪蕾,等.通腑汤直肠高位滴注的临床研究,北京中医药大学学报,2000;23(2):61-63.
34. 席军生,曹建春.肠源性 MODS. 中华实用中西医杂志,2005, 18(23): 1868-1869
35. 黄棉生,刘东举,庄业忠,等.针刺保护胃肠道肿瘤术后 TPN 过程肠黏膜屏障损害的临床研究.中国肿瘤临床与康复,2002,9(1):40.
36. 康复笑,韩宜印,何淑贤,等.生大黄促进术后胃肠功能恢复的临床观察.中国中西医结合外科杂志,2002,8(3):168
37. 夏中元,罗涛,夏芳,等.生脉注射液对肠黏膜再灌注损伤保护作用机制的实验研究[J].中华麻醉学杂志,2001,21(5):299-301.
38. 陈少夫,贺丽,周卓,等.党参对兔胃十二指肠黏膜中胃泌素 生长抑素的影响[J].中国医科大学学报,2002,31(3):164-165.
39. 王 万 铁 , 徐 正 , 林 丽 娜 , 等 . 川 芎 嗪 对 肠 黏 膜 屏 障 功 能 的 保 护 作 用 . 中 国 病 理 生 理 杂 志 2001,17(9):882-885.
40. 黑子清,林世清,刘卫峰,等.黄茂对失血性休克再灌注兔肠黏膜微循环血流量的影响.中华麻醉学杂志,2003,23(7): 543-544.
41. 刘 承 哲 , 刘 牧 林 . 大 黄 对 多 器 官 衰 竭 大 鼠 肠 黏 膜 屏 障 的 保 护 作 用 [J]. 蚌 埠 医 学 院 学报,1998,23(6):380-381.
42. 黄兴兰,陈晓理,贾成瑶,等.大黄对 Balb/c 小鼠肠黏膜屏障保护作用的机理探讨[J].四川医学,1999,20(5):486-487.
43. 赵卫川,崔乃强,赵琪.承气合剂对缺血再灌流肠管内毒素转运的影响[J].中国中西医结合外科杂志,1998,4(2):83-86.
44. 陈海龙,冯立民,关凤林.阳明腑实证患者肠黏膜屏障功能的改变及复方大承气汤干预作用的临床观察[J].中医杂志,2003,44(9):672-673.
45. 李钢,陈海平,王凯成,等.中药合剂 AA3 保护实验性急性胰腺炎大鼠肠黏膜屏障的研究. 中国危重病急救医学,1999,11(5): 273-275.
46. 尤家平,蒋道国,李广元.芪连液保留灌肠治疗婴幼儿秋季腹泻临床与实验研究.中国中西医结合杂志,2000,20(9):664.
47. 张晓峰,苏佩清,任建素,等.中药清肠栓对溃疡性结肠炎大鼠实验模型的影响.河北医学,1998,4(5):1
48. 次秀丽,王宝恩,张淑文,等.肿瘤坏死因子和内毒素致大鼠肠黏膜屏障损伤的中药治疗研究.中国危重病急救医学,1999,11(5):262.
49. 宋路线,徐迎新,宋旭华,等.大黄煎剂延迟并下调肠道相关淋巴细胞凋亡.实用医学杂志,2000,16(7):530.
50. 曹建春,李乃卿.肠源性 MODS 研究现状.中华中西医临床杂志,2005,5(12):912-916.
1. Karime R,Matsumoto S,Higashi H et al . The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today,1999,5 (8) :123-132.
2. Perti P,Mazzei T. Antibiotic2induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock : a review. J Chemother,1998,10 (5) : 427-448.
3. 田牛,主编. 微循环方法学. 北京: 原子能出版社,1993. 12,1-233.
4. Song Y,Shen H. Protective effect of naloxone on rat cortical neuron induced by hypoxia. Chin J Emerg Med,2004,13 (3) : 155-157.
5. 川崎博已.肠系膜微循环与血管周围神经性调节.日本医学介绍,2002,23(11): 504-505
6. Cohen J.The detection and interpretation of endotoxaemia. Intesive Care Med,2000,26(suppl): 51-56.
7. 符庆瑛,李著华,张艳青,等.PGI2 对肾缺血再灌损伤兔肠系膜微循环和血液流变性的影响.中国病理生理杂志,2005 ,21(2) :361 - 366
8. 张钢, 高钰琪, 刘福玉. 急性缺氧对大鼠肠系膜微循环白细胞流变学行为的影响. 第三军医大学学报,2002,24(3) : 320 - 322.
9. Yokoyama C , Yebuki T, Shimonishi M, et al. Prostacyclin-deficient mice develop ischemic renal disorders , including nephrosclerosis and renal infarction [ J ] . Circulation , 2002 ,106 (18) : 2397 - 2403.
10. Fujita T, Fuke Y, Satomura A , et al. PGI2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency [ J ] . Prostaglandins Leukot Essent Fatty Acids , 2001 , 65(4) : 223 - 227.
11. 丁库克, 曾衍钧, 廖东华,等. 脑缺血及再灌注对血液粘度与红细胞变形性的影响. 首都医科大学学报,2001 , 22(1) : 6 - 9.
12. Habon T, Szabados E , Kesmarky G, et al. The effect of carvedilol on enhanced ADP - ribosylation and red blood cell membrane damage caused by free radicals. Cardiovasc Res.2001.52(1) :153 -160.
13. Kozek - Langenecker SA , Spiss CK, Michalek - Sauberer A , et al. Effect of prostacyclin on platlets , polymorphonuclear cell , and heterotypic cell aggregation during hemofiltration[J ] .Crit Care Med , 2003 , 31(3) : 864 - 868.
14. 王怡, 王仰宗. 实用临床血液流变学[M] . 北京: 学苑出版社, 1994. 41 - 41.
15. Jahr J , Ekelund U , Grande PO. In vivo effects of prostacyclin on segmental vascular resistances ,on myogenic reactivity ,and on capillary fluid exchange in cat skeletal muscle [ J ] . Crit Care Med , 1995 , 23(3) : 523 - 531.
16. 宋益民,李学坤,谭建民,等.阿司匹林、维拉帕米单用和合用对大鼠肠系膜微循环的影响.中国临床药理学与治疗学, 2001 ;6(1): 31-34
17. 千智斌,姬明丽.急性右心衰竭兔中心静脉压及颈总动脉压与肠系膜微循环的关系.新乡医学院学报,2001,18(2 ):88-90
18. 宋康兴,沈洪,朱海燕,等.纳洛酮对内毒素血症大鼠肠系膜微循环变化的影响.中华急诊医学杂志,2005,14 (5):391-393
19. 王柏生. 临床血液流变学[M] . 第 1 版. 郑州: 河南医科大学出版社, 1999. 76 - 77.
1. Bruch JM, Moore EE, Moore FA, et al. The abdominal compartment syndrome. Surg Clin North Am,1996;76:833-842.
2. 李乃卿主编.中西医结合外科学.北京:中国中医药出版社,2005,第 1 版:213-216
3. 解基良,张志尧,吴咸中.承气方剂对肠屏障功能保护作用的实验研究. 中国中西医结合外科杂志.2002,8(3):189-191.
4. 倪孝儒,李雪蕾,曹建春.通腑汤高位直肠滴入治疗重症急性胰腺炎 46 例临床观察,中华中西医临床杂志,2004;4(7):814-815.
5. 邓轶,陈航,崔朝阳,等. 通腑汤保留灌肠治疗急性胰腺炎 45 例,北京中医药大学学报,2000,23:59-61
6. 孙欣,李乃卿.经肛肠途径营养支持的可行性探讨,中华中西医临床杂志,2003,3(6):683-689
7. 李乃卿.高位直肠滴入通腑汤的疗效观察。北京中医,1992,33(4):56-57.
8. 滕占庆,李乃卿。通腑汤调理胃肠道功能的疗效观察,中国中西医结合外科杂志,1997,3:102-104.
9. 倪孝儒,李乃卿,李雪蕾,等.通腑汤直肠高位滴注的临床研究,北京中医药大学学报,2000;23(2):61-63.
10. 曹建春,李乃卿.肠源性 MODS 研究现状.中华中西医临床杂志,2005,5(12):912-916.
11. 刘 承 哲 , 刘 牧 林 . 大 黄 对 多 器 官 衰 竭 大 鼠 肠 黏 膜 屏 障 的 保 护 作 用 [J]. 蚌 埠 医 学 院 学报,1998,23(6):380-381.
12. 黄兴兰,陈晓理,贾成瑶,等.大黄对 Balb/c 小鼠肠黏膜屏障保护作用的机理探讨[J].四川医学,1999,20(5):486-487.
13. 赵卫川,崔乃强,赵琪.承气合剂对缺血再灌流肠管内毒素转运的影响[J].中国中西医结合外科杂志,1998,4(2):83-86.
14. 陈海龙,冯立民,关凤林.阳明腑实证患者肠黏膜屏障功能的改变及复方大承气汤干预作用的临床观察.中医杂志,2003,44(9):672-673.
15. 吴承堂,黎沾良.中药清胰汤对犬急性坏死性胰腺炎肠黏膜损伤修复的影响.中国普外基础与临床杂志,1998,5(6):326-328.
16. 李钢,陈海平,王凯成,等.中药合剂 AA3 保护实验性急性胰腺炎大鼠肠黏膜屏障的研究. 中国危重病急救医学,1999,11(5): 273-275.
17. 康复笑,韩宜印,何淑贤,等.生大黄促进术后胃肠功能恢复的临床观察.中国中西医结合外科杂志,2002,8(3):168
18. 陈德昌,杨建东,景炳文,等.大黄对大鼠肠黏膜及肠血管通透性的影响. 中国危重病急救医学,1997,9(7):385-387.
19. 席军生,曹建春.肠源性 MODS. 中华实用中西医杂志,2005,18(23):1868-1869
2. Magnotti LJ, Deitch EA. Burns, bacterial translocation, gut barrier function, and failure. J Burn Care Rehabil. 2005 Sep-Oct;26(5):383-91. Review.
3. 李乃卿.重新认识胃肠道,中华中西医临床杂志,2004,4(7):773-774.
4. Wilmore DW. The gut: a central organ after surgical stress. Surgery. 1988,104:917.
5. 黎介寿.肠衰竭-概念、营养支持与肠黏膜屏障维护. 肠外与肠内营养,2004,11(2):65-67.
6. Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin. 2005 Apr;21(2):177-96. Review.
7. Deitch EA, Xu D, Kaise VL. Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci. 2006 Jan 1;11:520-8.
8. 陈海龙,王辉.肠道屏障功能障碍.见李永渝,陈锡美,王志荣主编.实用消化系统病理生理学(M).第 1 版.上海:同济大学出版社,2003:52-65.
9. Liu Z, Li N, Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr. 2005 Apr;94(4):386-93.
10. Watson CJ, Hoare CJ, Garrod DR, et al. Interferon-gamma selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores.J Cell Sci. 2005 Nov 15;118(Pt 22):5221-30. Epub 2005 Oct 25.
11. Shen L, Turner JR. Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: tight junction dynamics exposed. Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G577-82.
12. Hase K, Ohno H.Epithelial cells as sentinels in mucosal immune barrier. Nihon Rinsho Meneki Gakkai Kaishi. 2006 Feb;29(1):16-26.
13. Chang JX, Chen S, Jiang LY, et al. Effect of goblet cell in rat intestine on the restitution process of the gut barrier after hemorrhagic shock. Zhonghua Wei Chang Wai Ke Za Zhi. 2005 Nov;8(6):510-2.
14. Isolauri E, Salminen S. Probiotics, gut inflammation and barrier function. Gastroenterol Clin North Am. 2005 Sep;34(3):437-50, viii. Review. No abstract available.
15. Ismail AS, Hooper LV. Epithelial cells and their neighbors. IV. Bacterial contributions to intestinal epithelial barrier integrity.Am J Physiol Gastrointest Liver Physiol. 2005 Nov;289(5):G779-84.
16. Verdu EF, Bercik P, Bergonzelli GE, et,al. Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology. 2004 Sep;127(3):826-37.
17. Llopis M, Antolin M, Guarner F, et al. Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid.Gut. 2005 Jul;54(7):955-9.
18. Husebye E.The pathogenesis of gastrointestinal bacterial overgrowth.Chemotherapy. 2005;51 Suppl 1:1-22.
19. Zareie M, Riff J, Donato K, et al. Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function.Cell Microbiol. 2005 Dec;7(12):1782-97.
20. 丁连安.肠屏障功能障碍. 肠外与肠内营养. 2005,12(1):55-58.
21. Kleessen B, Blaut M. Modulation of gut mucosal biofilms.Br J Nutr. 2005 Apr;93 Suppl 1:S35-40.
22. Yang R, Harada T, Li J, et al. Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism.Intensive Care Med. 2005 May;31(5):709-17.
23. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology. 2005Mar;41(3):422-33.
24. Review. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2005 Jan;17(1):27-31.
25. 王克勤,马恩陵,温 泉,等.肠道免疫屏障中上皮层内淋巴细胞的特点及影响因素.中国临床营养杂志,2003,11(1):51-56
26. Allez M, Mayer L. Regulatory T cells: peace keepers in the gut. Inflamm Bowel Dis. 2004 Sep; 10(5):666-76.
27. Demaude J, Salvador-Cartier C, Fioramonti J, et al. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut. 2006 May;55(5):655-61.
28. Thompson-Chagoyan OC, Maldonado J, et al. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.Clin Nutr. 2005 Jun;24(3):339-52.
29. Diebel LN, Liberati DM, Dulchavsky SA, et al. Enterocyte apoptosis and barrier function are modulated by SIgA after exposure to bacteria and hypoxia/reoxygenation.Surgery. 2003 Oct;134(4):574-80; discussion 580-1.
30. Galdeano CM, Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol. 2006 Feb;13(2):219-26.
31. Bollinger RR, Everett ML, Wahl SD, et al. Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili. Mol Immunol. 2006 Feb;43(4):378-87.
32. Assimakopoulos SF, Thomopoulos KC, Patsoukis N, Evidence for intestinal oxidative stress in patients with obstructive jaundice. Eur J Clin Invest. 2006 Mar;36(3):181-7.
33. Shi D, Das J, Das G. Inflammatory bowel disease requires the interplay between innate and adaptive immune signals.Cell Res. 2006 Jan;16(1):70-4.
34. Deitch EA, Forsythe R, Anjaria D, et al. The role of lymph factors in lung injury, bone marrow suppression, and endothelial cell dysfunction in a primate model of trauma-hemorrhagic shock.. Shock. 2004 Sep;22(3):221-8.
35. 史颖辉,李学荣,胡大海,等.硝酸镧块染法显示肠黏膜屏障通透性的电镜技术.11-12.
36. Johnston SD, Smye M, Watson RP. Intestinal permeability tests in celiac disease. Clin Lab. 2002,47(3-4):143-150.
37. Farhadi A, Keshavarzian A, Fields JZ, et al. Resolution of common dietary sugars from probe sugars for test of intestinal permeability using capillary column gas chromatography.J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Apr 16; [Epub ahead of print]
38. Paroni R, Fermo I, Molteni L, et al. Lactulose and mannitol intestinal permeability detected by capillary electrophoresis.J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Apr 13;834(1-2):183-7.
39. Piquet MA, Laurent D, Manceau S, et al.Increased intestinal permeability in patients with cirrhosis. Gastroenterology. 1997,112(suppl4):A1360.
40. Jiang ZM, CAO JD, Zhu XG, et al.The impact of alanyk-gluyamine on clinical safety,nitrogen balance,intestinal permeability,and clinical outcome in postoperative patients:a randomized ,double blind,controlled study of 120 patients. JPEN. 1999,23(5):S62-65.
41. 蒋朱明,于康.肠黏膜屏障损害与肠外和肠内营养.外科理论与实践.2000,5(l):54-58
42. Generoso M, De Rosa M, De Rosa R, et al. Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jan 15;783(2):349-57.
43. Marsilio R, D'Antiga L, Zancan L, et al. Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clin Chem. 1998 Aug;44(8 Pt 1):1685-91.
44. Liu H, Zhang S, Yu A, et al. Studies on intestinal permeability of cirrhotic patients by analysis lactulose and mannitol in urine with HPLC/RID/MS. Bioorg Med Chem Lett. 2004 May 3;14(9):2339-44.
45. Schietroma M, Carlei F, Cappelli S, et al. Intestinal permeability and systemic endotoxemia after laparotomic or laparoscopic cholecystectomy. Ann Surg. 2006 Mar;243(3):359-63.
46. Di Leo V, D'Inca R, Diaz-Granado N, et al. Lactulose/mannitol test has high efficacy for excluding organic causes of chronic diarrhea.Am J Gastroenterol. 2003 Oct;98(10):2245-52.
47. Sukkar SG, Schenone E, Foppiani L, et al. Experimental assessment of chemotherapy-induced early intestinal damage in colon cancer the lactulose-mannitol permeability test. Tumori. 2004 Sep-Oct;90(5):461-3.
48. 郑治钢.尿 L/M 比值在估测肠黏膜屏障功能中的价值. 中国中西医结合外科杂志,2000,6(6):435-436.
49. 黎君友,吕艺,付小兵,等.二胺氧化酶在创伤后肠道损伤中变化及意义.中国危重病急救医学2000,12(8)482-484.
50. Quan ZF, Yang C, Li N, et al. Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World J Gastroenterol. 2004 Jul 1;10(13):1992-4.
51. Wei YJ, Wang RL, Li GP. Influence on the concentration of plasma endotoxin by inhibition of complement activation in traumatic hemorrhagic shock rats Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Mar;18(3):180-3.
52. 陈秀凯,蒲践一,邱方,等.二胺氧化酶与 D-乳酸对脑损伤大鼠肠屏障功能的监测意义.中国煤炭工业医学杂志,2003,6(7): 669-671.
53. Li Z, Yang X, Lu L, et al. Gut barrier function damage following multiple firearm injuries in a porcine model.Chin Med Sci J. 2001 Dec;16(4):209-13.
54. Yang X, Li Z, Lu L, et al. An experiment of gut barrier function damage following multiple firearm injuries in a porcine model. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Oct;22(5):428-31.
55. Ruan P, Gong ZJ, Zhang QR. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin inpatients with liver cirrhosis. Hepatobiliary Pancreat Dis Int. 2004 Feb;3(1):58-61.
56. 吴承堂 , 黎沾良 . 二胺氧化酶在急性坏死性胰腺炎肠道损伤中的作用 . 世界华人消化杂志,1999;7(1):64-65.
57. 姚咏明,盛志勇,吴叶,等.大鼠急性肠缺血后 D-乳酸的变化及其与肠黏膜损害的关系[J].中华烧伤整形外科杂志,1998,4(4):266-269.
58. 孙晓庆,付小兵,张蓉,等.创伤后肠道通透性改变血浆标志物 D-乳酸的实验研究.中国危重病急救医学,2000,12(8)476-478.
59. Han X, Fink MP, Yang R, et al. Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice. Shock. 2004 Mar;21(3):261-70.
60. O'Brien DP, Nelson LA, Kemp CJ, et al. Intestinal permeability and bacterial translocation are uncoupled after small bowel resection.J Pediatr Surg. 2002 Mar;37(3):390-4.
61. Yang R, Harada T, Li J, et al. Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism. Intensive Care Med. 2005 May;31(5):709-17.
62. 彭曦,汪仕良,王斐,等.肠道营养支持对烧伤大鼠肠黏膜屏障功能的保护作用及其机理.基础医学与临床, 2001,21(4):352-355.
63. 常建星, 黄子通, 蒋龙元,等.肠屏障损伤后通透性与形态学改变的相关性研究.中国急救医学,2004,24(11):806-807.
64. Solligard E, Juel IS, Bakkelund K, et al. Gut barrier dysfunction as detected by intestinal luminal microdialysis. Intensive Care Med. 2004 Jun;30(6):1188-94. Epub 2004 Feb 28.
65. Gosain A, Gamelli RL. Role of the gastrointestinal tract in burn sepsis. J Burn Care Rehabil. 2005 Jan-Feb;26(1):85-91.
66. 赵 钢,江 伟,徐惠芳.大黄对肠缺血再灌注致大鼠炎症反应的防治作用. 南京铁道医学院学报2000;19(4):246-249.
67. Holland J, Carey M, Hughes N, et al. Intraoperative splanchnic hypoperfusion, increased intestinal permeability, down-regulation of monocyte class II major histocompatibility complex expression, exaggerated acute phase response, and sepsis. Am J Surg. 2005 Sep;190(3):393-400.
68. Deitch EA, Lu Q, Feketeova E,et al. Intestinal bacterial overgrowth induces the production of biologically active intestinal lymph. J Trauma. 2004 Jan;56(1):105-10.
69. Lozano FS, Barros MB, Fresnadillo MJ, et al. Nitric oxide prevents the bacterial translocation and inhibits the systemic inflammatory response produced by implantation of a vascular prosthesis followed by Zymosan A. Inflamm Res. 2005 Jun;54(6):261-70.
70. Solaroglu I, Okutan O, Kaptanoglu E, et al. Increased xanthine oxidase activity after traumatic brain injury in rats. J Clin Neurosci. 2005 Apr;12(3):273-5.
71. Lu BY, Chang JY. Assay of disulfide oxidase and isomerase based on the model of hirudin folding.Anal Biochem. 2005 Apr 1;339(1):94-103.
72. Odachi T, Koga S. Effects of long-term parenteral nutrition on gastrin release in dogs. Zentralbl Chir. 1987;112(13):863-8.
73. Alverdy J, Zaborina O, Wu L.The impact of stress and nutrition on bacterial-host interactions at theintestinal epithelial surface. Curr Opin Clin Nutr Metab Care. 2005 Mar;8(2):205-9. Review.
74. Davidson MT, Deitch EA, Lu Q, et al. A study of the biologic activity of trauma-hemorrhagic shock mesenteric lymph over time and the relative role of cytokines. Surgery. 2004 Jul;136(1):32-41.
75. Qin HL, Shen TY, Gao ZG, et al. Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection.World J Gastroenterol. 2005 May 7;11(17):2591-6.
76. Boikov SS, Moroz AF, Babaeva EE. Association of Candida albicans fungi with some opportunistic microorganisms in intestinal dysbiosis in patients of different age groups. Zh Mikrobiol Epidemiol Immunobiol. 2005 Mar-Apr;(2):65-9.
77. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut. 2001 Feb;48(2):198-205.
78. Homma H, Hoy E, Xu DZ, et al. The female intestine is more resistant than the male intestine to gut injury and inflammation when subjected to conditions associated with shock states.Am J Physiol Gastrointest Liver Physiol. 2005 Mar;288(3):G466-72.
79. Kasman LM. Barriers to coliphage infection of commensal intestinal flora of laboratory mice. Virol J. 2005 Apr 15;2:34.
80. Neal MD, Leaphart C, Levy R, et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol. 2006 Mar 1;176(5):3070-9.
81. Choda Y, Morimoto Y, Miyaso H, et al. Failure of the gut barrier system enhances liver injury in rats: protection of hepatocytes by gut-derived hepatocyte growth factor. Eur J Gastroenterol Hepatol. 2004 Oct;16(10):1017-25.
82. Schietroma M, Carlei F, Cappelli S,et,al. Intestinal permeability and systemic endotoxemia after laparotomic or laparoscopic cholecystectomy. Ann Surg. 2006 Mar;243(3):359-63.
83. 贾玉红,贾玉杰.内毒素血症与消化道疾病.见李永渝,陈锡美,王志荣主编.实用消化系统病理生理学(M).第 1 版.上海:同济大学出版社,2003:66-75.
84. Enomoto N, Takei Y, Yamashina S, et al. Burn injury sensitizes rat Kupffer cells via mechanisms dependent on gut-derived endotoxin.J Gastroenterol. 2004 Dec;39(12):1175-81.
85. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2005 Jan;17(1):45-51.
86. Qi W, Ebbert KV, Craig AW,et al. Absence of Fer protein tyrosine kinase exacerbates endotoxin induced intestinal epithelial barrier dysfunction in vivo. Gut. 2005 Aug;54(8):1091-7.
87. Pull SL, Doherty JM, Mills JC, et al. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury.Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):99-104.
88. Soderholm JD, Streutker C, Yang PC, et al. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.Gut. 2004 Dec;53(12):1817-24.
89. 曹建春,李乃卿.肠源性 MODS 研究现状.中华中西医临床杂志,2005,5(12):912-916.
90. Wang B, Glatzle J, Mueller MH, et al. Lipopolysaccharide-induced changes in mesenteric afferentsensitivity of rat jejunum in vitro: role of prostaglandins. Am J Physiol Gastrointest Liver Physiol. 2005 Aug;289(2):G254-60. Epub 2005 Mar 24.
91. Moriez R, Salvador-Cartier C, Theodorou V,et al. Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats.Am J Pathol. 2005 Oct;167(4):1071-9.
92. Schietroma M, Carlei F, Cappelli S,et al. Intestinal permeability and systemic endotoxemia after laparotomic or laparoscopic cholecystectomy. Ann Surg. 2006 Mar;243(3):359-63.
93. Stallion A, Kou TD, Latifi SQ, et al. Ischemia/reperfusion: a clinically relevant model of intestinal injury yielding systemic inflammation.J Pediatr Surg. 2005 Mar;40(3):470-7.
94. Horie Y, Han JY, Mori S, et al. Herbal cardiotonic pills prevent gut ischemia/reperfusion-induced hepatic microvascular dysfunction in rats fed ethanol chronically. World J Gastroenterol. 2005 Jan 28;11(4):511-5.
95. Chin J. Intestinal microflora: negotiating health outcomes with the warring community within us. Asia Pac J Clin Nutr. 2004;13(Suppl):S24-5.
96. Qin HL, Su ZD, Gao Q,et al. Early intrajejunal nutrition: bacterial translocation and gut barrier function of severe acute pancreatitis in dogs. Hepatobiliary Pancreat Dis Int. 2002 Feb;1(1):150-4.
97. Enomoto N, Takei Y, Yamashina S, et al. Burn injury sensitizes rat Kupffer cells via mechanisms dependent on gut-derived endotoxin.J Gastroenterol. 2004 Dec;39(12):1175-81.
98. Krack A, Sharma R, Figulla HR, et al. The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J. 2005 Nov;26(22):2368-74.
99. Krasnik L, Szponar B, Walczak M, et al. Routine clinical laboratory tests correspond to increased serum levels of 3-hydroxy fatty acids, markers of endotoxins, in cardiosurgery patients. Arch Immunol Ther Exp (Warsz).2006 Jan-Feb; 54(1): 55-60.
100. Ruhl A, Nasser Y,Sharkey KA.Enteric glia.Neurogastroenterol Motil. 2004,Apr;16 Suppl1:44-9.
101. Filos KS, Kirkilesis I, Spiliopoulou I, et al. Bacterial translocation, endotoxaemia and apoptosis following Pringle manoeuvre in rats. Injury. 2004 Jan;35(1):35-43.
102. Luyer MD, Buurman WA, Hadfoune M, et al. Pretreatment with high-fat enteral nutrition reduces endotoxin and tumor necrosis factor-alpha and preserves gut barrier function early after hemorrhagic shock. Shock. 2004 Jan;21(1):65-71.
103. Kennedy JA, Clements WD, Kirk SJ, et al. Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice. Br J Surg. 1999 May;86(5):628-33.
104. Wang YY, Dahle MK, Agren J, et al. Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation.Shock. 2006 Feb;25(2):141-6.
105. Yao HW, Yue L. Effect and mechanisms of FR167653, a dual inhibitor of TNF-alpha and IL-1, on BCG plus LPS induced-liver injury. Inflamm Res. 2005 Nov;54(11):471-7.
106. Enomoto N, Takei Y, Yamashina S, et al. Burn injury sensitizes rat Kupffer cells via mechanisms dependent on gut-derived endotoxin.J Gastroenterol. 2004 Dec;39(12):1175-81.
107. Miyaso H, Morimoto Y, Ozaki M, et al. Obstructive jaundice increases sensitivity tolipopolysaccharide via TLR4 upregulation: possible involvement in gut-derived hepatocyte growth factor-protection of hepatocytes. J Gastroenterol Hepatol. 2005 Dec;20(12):1859-66.
108. Giacometti A, Cirioni O, Ghiselli R, et al. Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. Gut. 2003 Jun;52(6):874-8.
109. Jonassen TE, Graebe M, Promeneur D, et al. Lipopolysaccharide-induced acute renal failure in conscious rats: effects of specific phosphodiesterase type 3 and 4 inhibition. J Pharmacol Exp Ther. 2002 Oct;303(1):364-74.
110. Cunha MA, Schor N. Effects of gentamicin, lipopolysaccharide, and contrast media on immortalized proximal tubular cells. Ren Fail. 2002 Nov;24(6):687-90.
111. Venkatesh B, Morgan TJ, Hall J,et al. Subcutaneous gas tensions closely track ileal mucosal gas tensions in a model of endotoxaemia without anaerobism. Intensive Care Med. 2005 Mar;31(3):447-53.
112. Diebel LN, Liberati DM, Baylor AE 3rd, et al. The pivotal role of tumor necrosis factor-alpha in signaling apoptosis in intestinal epithelial cells under shock conditions.J Trauma. 2005 May;58(5):995-1001.
113. 丁连安 黎介寿 李幼生,等.创伤及内毒素对大鼠肠屏障功能的损害 . 中华实验外科杂志,2004,2(6):697-699.
114. Kuru B, Dinc S, Altinok G, et al. Effect of different enteral nutrients on bacterial translocation in experimental obstructive jaundice. Eur Surg Res. 2004 Jan-Feb;36(1):45-52.
115. 彭 曦 , 汪 仕 良 , 尤 忠 义 , 等 . 肠 道 营 养 减 轻 严 重 烧 伤 所 致 肠 道 损 害 的 实 验 研 究 . 重 庆 医学,2002,(31)3:198-200.
116. 李元新, 李宁, 蒋小华,等.肠内营养对术后病人营养支持疗效的前瞻、随机、对照临床研究.肠外与肠内营养.2003,10(1):34-37.
117. 吴国豪.肠屏障功能障碍及防治对策.肠外与肠内营养, 2004,11(5): 313-316
118. Margaritis VG, Filos KS, Michalaki MA, et al. Effect of oral glutamine administration on bacterial tanslocation, endotoxemia, liver and ileal morphology, and apoptosis in rats with obstructive jaundice. World J Surg. 2005 Oct;29(10):1329-34.
119. Domeneghini C, Di Giancamillo A, Bosi G, et al. Can nutraceuticals affect the structure of intestinal mucosa? Qualitative and quantitative microanatomy in L-glutamine diet-supplemented weaning piglets.Vet Res Commun. 2006 Apr;30(3):331-42.
120. Coeffier M, Dechelotte P. The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome.Nutr Rev. 2005 Feb;63(2):65-9.
121. Hulsewe KW, van der Hulst RW, et al. Inflammation rather than nutritional depletion determines glutamine concentrations and intestinal permeability. Clin Nutr. 2004 Oct;23(5):1209-16.
122. Hulsewe KW, van Acker BA, Hameeteman W, et al. Does glutamine-enriched parenteral nutrition really affect intestinal morphology and gut permeability? Clin Nutr. 2004 Oct;23(5):1217-25.
123. Assimakopoulos SF, Vagianos CE, Zervoudakis G, et al. Gut regulatory peptides bombesin and neurotensin reduce hepatic oxidative stress and histological alterations in bile duct ligated rats. RegulPept. 2004 Aug 15;120(1-3):185-93.
124. Assimakopoulos SF, Scopa CD, Charonis A, et al. Experimental obstructive jaundice disrupts intestinal mucosal barrier by altering occludin expression: beneficial effect of bombesin and neurotensin. J Am Coll Surg. 2004 May;198(5):748-57.
125. Ding LA, Li JS, Li YS, et al. Prophylactic treatment with growth hormone improves intestinal barrier function and alleviates bacterial translocation in stressed rats. Chin Med J (Engl). 2004 Feb;117(2):264-9.
126. Feng J, El-Assal ON, Besner GE. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats.J Pediatr Surg. 2006 Jan;41(1):144-9; discussion 144-9.
127. Assimakopoulos SF, Alexandris IH, Scopa CD, et al. Effect of bombesin and neurotensin on gut barrier function in partially hepatectomized rats.World J Gastroenterol. 2005 Nov 21;11(43):6757-64.
128. Howe KL, Reardon C, Wang A, et al. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am J Pathol. 2005 Dec;167(6):1587-97.
129. 郑永波,吴承堂,黄祥成.L-精氨酸对严重腹腔感染大鼠肠屏障功能的影响. 中华急诊医学杂志2004,13(10):655-657.
130. Wischmeyer PE. Clinical applications of L-glutamine: past, present, and future. Nutr Clin Pract. 2003 Oct;18(5):377-85.
131. Tuohy KM,Rouzaud GC, Bruck WM, et al. Modulation of the human gut microflora towards improved health using prebiotics--assessment of efficacy. Curr Pharm Des. 2005;11(1):75-90.
132. Broekaert IJ, Walker WA. Probiotics as flourishing benefactors for the human body. Gastroenterol Nurs. 2006 Jan-Feb;29(1):26-34.
133. Brink M, Todorov SD, Martin JH, et al. The effect of prebiotics on production of antimicrobial compounds, resistance to growth at low pH and in the presence of bile, and adhesion of probiotic cells to intestinal mucus. J Appl Microbiol. 2006 Apr;100(4):813-20.
134. 邓群,黎沾良, 熊德鑫.选择性消化道灭菌对急性胰腺炎肠源性内毒素血症的预防作用. 中国外基础与临床杂志,2001, 8(6) : 361-363.
135. 陈海龙,刘艳,吴咸中,等.多器官功能不全综合征时肠道细菌易位及通里攻下法影响的实验研究. 中国微生态学杂志, 1998,10(6):342-346.
136. Kelly N, Friend K, Boyle P, et al. The role of the glutathione antioxidant system in gut barrier failure in a rodent model of experimental necrotizing enterocolitis. Surgery. 2004 Sep; 136(3):557-66.
137. Aw TY. Intestinal glutathione: determinant of mucosal peroxide transport, metabolism, and oxidative susceptibility. Toxicol Appl Pharmacol. 2005 May 1;204(3):320-8.
138. Koutelidakis I, Papaziogas B, Giamarellos-Bourboulis EJ, et al. Systemic endotoxaemia following obstructive jaundice: the role of lactulose. J Surg Res. 2003 Aug;113(2):243-7.
139. Zeissig S, Bojarski C, Buergel N, et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut. 2004Sep;53(9):1295-302. Erratum in: Gut. 2004 Nov;53(11):1722.
140. Malagon I, Onkenhout W, Klok M, et al. Dexamethasone reduces gut permeability in pediatric cardiac surgery.J Thorac Cardiovasc Surg. 2005 Aug;130(2):265-71.
141. 曹建春,张东萍,李乃卿.肠源性 MODS 的发生机制.医学研究杂志, 2006,35(2):56-57.
142. 张亚瑞,唐方. 中医药对肠屏障功能保护作用的研究概况.浙江中医杂志,2005,(3):133-135.
143. 刘蓉,唐方.中药保护肠屏障功能研究概况. 上海中医药杂志,2004, 38(12):57-59.
144. 张子理,陈蔚文.党参、黄芪、白术、甘草提取部位对小肠上皮细胞增殖的影响.中药药理与临床,2002,18(1):10-12.
145. 张 子 理 , 陈 蔚 文 . 黄 芪 注 射 液 和 白 术 提 取 部 位 对 小 肠 上 皮 细 胞 移 行 的 影 响 . 中 草药,2002,33(10):912-915.
146. 吴承堂,黎沾良.中药清胰汤对犬急性坏死性胰腺炎肠黏膜损伤修复的影响.中国普外基础与临床杂志,1998,5(6):326-328.
147. 姚永莉,宋于刚,张万岱.四君子汤治疗实验脾虚证对胃肠黏膜细胞增殖动力学的影响[J].世界华人消化杂志,1999,7(6):550.
148. 张建平,许利剑,徐凛峰,等.银杏叶提取物对大鼠实验性重症胰腺炎肠黏膜屏障功能的影响.江苏医药,2004,30(1): 18-20.
149. 王孟清,欧正武,吴明侦,等.健运冲剂促脾虚泄泻模型大鼠受损肠黏膜修复的研究[J].中国中西医结合脾胃杂志,1999,7(4):217-219.
150. 谢肄聪,唐方.藿香正气软胶囊对肠屏障功能保护作用的实验研究.中草药,2003,34(3):252-254.
151. 邱 奇,崔乃强,吴咸中.大承气冲剂对腹腔感染所致 SIRS/MODS 的治疗作用. 中国中西医结合外科杂志,2004, 10(4): 239-243.
152. 陈海龙,吴咸中,关凤林,等.中医攻里通下法对多脏器功能不全征时肠道屏障功能保护作用的实验研究.中国中西医结合杂志,2000,20(2):120.
153. 陈德昌,杨建东,景炳文,等.大黄对大鼠肠黏膜及肠血管通透性的影响. 中国危重病急救医学,1997,9(7):385-387.
154. 解基良,张志尧,吴咸中.承气方剂对肠屏障功能保护作用的实验研究. 中国中西医结合外科杂志.2002,8(3):189-191.
155. 倪孝儒,李雪蕾,曹建春.通腑汤高位直肠滴入治疗重症急性胰腺炎 46 例临床观察,中华中西医临床杂志,2004;4(7):814-815.
156. 邓轶,陈航,崔朝阳,等. 通腑汤保留灌肠治疗急性胰腺炎 45 例,北京中医药大学学报,2000,23:59-61
157. 孙欣,李乃卿.经肛肠途径营养支持的可行性探讨,中华中西医临床杂志,2003,3(6):683-689
158. 李乃卿.高位直肠滴入通腑汤的疗效观察。北京中医,1992,33(4):56-57.
159. 滕占庆,李乃卿。通腑汤调理胃肠道功能的疗效观察,中国中西医结合外科杂志,1997,3:102-104.
160. 倪孝儒,李乃卿,李雪蕾,等.通腑汤直肠高位滴注的临床研究,北京中医药大学学报,2000;23(2):61-63.
161. 黄棉生,刘东举,庄业忠,等.针刺保护胃肠道肿瘤术后 TPN 过程肠黏膜屏障损害的临床研究.中国肿瘤临床与康复,2002,9(1):40.
162. 康复笑,韩宜印,何淑贤,等.生大黄促进术后胃肠功能恢复的临床观察.中国中西医结合外科杂志,2002,8(3):168
163. 夏中元,罗涛,夏芳,等.生脉注射液对肠黏膜再灌注损伤保护作用机制的实验研究[J].中华麻醉学杂志,2001,21(5):299-301.
164. 陈少夫,贺丽,周卓,等.党参对兔胃十二指肠黏膜中胃泌素 生长抑素的影响[J].中国医科大学学报,2002,31(3):164-165.
165. 王 万 铁 , 徐 正 , 林 丽 娜 , 等 . 川 芎 嗪 对 肠 黏 膜 屏 障 功 能 的 保 护 作 用 . 中 国 病 理 生 理 杂 志 2001,17(9):882-885.
166. 黑子清,林世清,刘卫峰,等.黄茂对失血性休克再灌注兔肠黏膜微循环血流量的影响.中华麻醉学杂志,2003,23(7): 543-544.
167. 刘 承 哲 , 刘 牧 林 . 大 黄 对 多 器 官 衰 竭 大 鼠 肠 黏 膜 屏 障 的 保 护 作 用 [J]. 蚌 埠 医 学 院 学报,1998,23(6):380-381.
168. 黄兴兰,陈晓理,贾成瑶,等.大黄对 Balb/c 小鼠肠黏膜屏障保护作用的机理探讨[J].四川医学,1999,20(5):486-487.
169. 赵卫川,崔乃强,赵琪.承气合剂对缺血再灌流肠管内毒素转运的影响[J].中国中西医结合外科杂志,1998,4(2):83-86.
170. 陈海龙,冯立民,关凤林.阳明腑实证患者肠黏膜屏障功能的改变及复方大承气汤干预作用的临床观察[J].中医杂志,2003,44(9):672-673.
171. 李钢,陈海平,王凯成,等.中药合剂 AA3 保护实验性急性胰腺炎大鼠肠黏膜屏障的研究. 中国危重病急救医学,1999,11(5): 273-275.
172. 尤家平,蒋道国,李广元.芪连液保留灌肠治疗婴幼儿秋季腹泻临床与实验研究.中国中西医结合杂志,2000,20(9):664.
173. 张晓峰,苏佩清,任建素,等.中药清肠栓对溃疡性结肠炎大鼠实验模型的影响.河北医学,1998,4(5):1.
174. 次秀丽,王宝恩,张淑文,等.肿瘤坏死因子和内毒素致大鼠肠黏膜屏障损伤的中药治疗研究.中国危重病急救医学,1999,11(5):262.
175. 宋路线,徐迎新,宋旭华,等.大黄煎剂延迟并下调肠道相关淋巴细胞凋亡.实用医学杂志,2000,16(7):530.
176. 席军生,曹建春.肠源性 MODS. 中华实用中西医杂志,2005,18(23):1868-1869.
1. Cheatham ML. Intra-abdominal hypertension and abdominal compartment syndrome[J] .NewHorizons,1999,7(1):96～115.
2. Kron IL, Harman PK, Nolan SP. The measurement of intra-abdominal pressure as a criterion for abdominal re-exploration[J].Ann Surg,1984;199(1):28.
3. Hong JJ, Cohn SM, Perez JM, et al. Prospective study of the incidence and outcome of intra2abdominal hypertension and the abdominal compartment syndrome[J]. Br J Surg, 2002,89 (5):591-596.
4. 汤耀卿,雷若庆. 提高对重症急性胰腺炎合并腹腔间隔室综合征的认识. 外科理论与实践. 2001,6 (6) :361-362.
5. Malbrain ML, Deeren D, De Potter TJ.Intra-abdominal hypertension in the critically ill: it is time to pay attention. Curr Opin Crit Care. 2005 Apr;11(2):156-71.
6. Swan MC, Banwell PE. The open abdomen: aetiology, classification and current management strategies. J Wound Care. 2005 Jan;14(1):7-11.
7. Miller RS, Morris JA Jr, Diaz JJ Jr, et,al. Complications after 344 damage-control open celiotomies. J Trauma. 2005 Dec;59(6):1365-71; discussion 1371-4.
8. Espeel B, Gerard C, Nzamuche JR,et,al. Late abdominal compartment syndrome secondary to traumatic gallbladder rupture. Gastroenterol Clin Biol. 2005 Apr;29(4):453-5.
9. Lambert DM, Marceau S, Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg. 2005 Oct;15(9):1225-32.
10. Jensen AR, Hughes WB, Grewal H. Secondary Abdominal Compartment Syndrome in Children With Burns and Trauma: A Potentially Lethal Complication. J Burn Care Res. 2006 March/April;27(2):242-246.
11. Britt RC, Gannon T, Collins JN, et, al. Secondary abdominal compartment syndrome: risk factors and outcomes. Am Surg. 2005 Nov;71(11):982-5.
12. Hsu YP, Chen RJ, Fang JF, et,al. Increased susceptibility to oxidant injury in hepatocytes from rats with intra-abdominal hypertension. J Trauma. 2004 Sep;57(3):569-75.
13. Serpytis M, Ivaskevicius J. Intra-abdominal hypertension and multiple organ dysfunction syndrome. Medicina (Kaunas). 2005;41(11):903-9.
14. Shiiya N, Matsuzaki K, Miyatake T, et,al. Abdominal compartment syndrome causing respiratory failure during surgery for a ruptured descending thoracic aneurysm: report of a case. Surg Today. 2005;35(4):320-2.
15. Simon RJ, Friedlander MH,Ivatury RR,et al. Hemorrhage lower thethreshold for intra-abdominal hypertension(IAH) induced pulmonary dysfunction[J].J Trauma,1997;42(3):398
16. Stagnitti F, Calderale SM, Priore F, et,al. Abdominal compartment syndrome: patophysiologic and clinic remarks. G Chir. 2004 Oct;25(10):335-42.
17. Bloomfield GL,Blocher CR,Fakhry IF,et al. Elevated intra-abdominal pressure Increases plasma rennin activity and aldosterone levels[J].J Trauma,1997;42(6):997
18. Ma YM, Qian C, Xie F, et,al. Acute renal failure due to abdominal compartment syndrome. Zhonghua Yi Xue Za Zhi. 2005 Aug 17;85(31):2218-20.
19. de Jong IJ, Veeken H, van der Heide K, Clinical reasoning and decision-making in practice. A patientwith oliguria following prostatectomyNed Tijdschr Geneeskd. 2005 Dec 3;149(49):2720-7.
20. Diebel LN , Dulchavsky SA, Brown WJ. Splanchnic ischemia and bacterial translocation in the abdominal compartment syndrome[J]. J Trauma , 1997 ; 43 (5): 852
21. Bloomfield GL, Ridings PC, Blocher CR, et al. Aproposed relationship between increased intra-abdominal, intrathoracic, and intracranial pressure[J].Crit Care Med,1997;25(3):496
22. Bloomfield GL,Dalton JM,Sugerman HJ,et al.Treatment of increasing intracranial pressure secondary to the acute abdominal compartment syndrome in a patient with combined abdominal and head trauma[J].J Trauma,1995;39(6):1168
23. Pirson J, Zizi M, Jacob E, et,al. Acute ischemic optic neuropathy associated with an abdominal compartment syndrome in a burn patient. Burns. 2004 Aug;30(5):491-4.
24. Kutayli ZN, Domingo CB, Steinberg SM. Intestinal failure. Curr Opin Anaesthesiol. 2005 Apr;18(2):123-7.
25. Yagci G, Zeybek N, Kaymakcioglu N,et,al. Increased intra-abdominal pressure causes bacterial translocation in rabbits. J Chin Med Assoc. 2005 Apr;68(4):172-7.
26. 程君涛,肖光夏,夏培元,等.腹内高压对兔肠道通透性及内毒素细菌移位的影响.中华烧伤杂志2003,19(4):229-232.
27. Nast-Kolb D, Bail HJ, Taeger G.Current diagnostics for intra-abdominal trauma. Chirurg. 2005 Oct;76(10):919-26.
28. 李彤,许媛,毛羽. 腹腔室隔综合征的诊断与治疗. 腹部外科,2004,17(3):192-194.
29. Nagappan R, Ernest D, Whitfield A. Recognition and Management of Intra-abdominal Hypertension and Abdominal Compartment Syndrome. Crit Care Resusc. 2005 Dec;7(4):298-302.
30. Ertal W, Oberholzer A, Platz A, et al. Incidence and clinical pattern of the abdominal compartment syndrome after “damage-control”laparotomy in 311 patients with severe abdominal and/or pelvic trauma. Crit Care Med, 2000, 28: 1747-1753.
31. Burch JM, Moore EE, Moore FA, et al. The abdominal compartment syndrome. Surg Clin North Am,1996,76:833-842.
32. Maxwell RA, Fabian TC,Croce MA, et al.Secondary abdominal compartment syndrome: An under appreciated manifestation of severe hemorrhagic shock. J Trauma, 1999,47:995-999.
33. Ivy ME, Atweth NA,Palmer J, et al. Intra-abdominal hypertension and abdominal compartment syndrome in burn patients. J Trauma, 2000, 49: 387-391.
34. McNelis J, Marini CP, Jurkiewicz A, et al. Predictive factors associated with the development of abdominal compartment syndrome in the surgical intensive care unit. Arch Surg,2002,137:133-136.
35. Chen RJ , Fang JF , Chen MF. Intra-abdominal pressure monitoring as a guideline in the nonoperative management of blunt hepatic trauma [J]. J Trauma, 2001; 51 (1): 44.
36. Brooks AJ, Simpson A, Delbridge M, et,al. Validation of direct intraabdominal pressure measurement using a continuous indwelling compartment pressure monitor. J Trauma. 2005 Apr;58(4):830-2.
37. Kural T, Brabec M, Kuda J, The importance of measuring intraabdominal pressure in cases of severe acute pancreatitis. Zentralbl Chir. 2005 Apr;130(2):128-31.
38. Chan S, Doughan S. Intra-abdominal hypertension and the abdominal compartment syndrome . Br J Surg 2004; 91: 1102-1110.
39. Ravishankar N, Hunter J.Measurement of intra-abdominal pressure in intensive care units in the United Kingdom: a national postal questionnaire study. Br J Anaesth. 2005 Jun;94(6):763-6. Epub 2005 Mar 11.
40. Balogh Z, Jones F, D'Amours S, et,al. Continuous intra-abdominal pressure measurement technique. Am J Surg. 2004 Dec;188(6):679-84.
41. Pickhardt PJ,Shimony JS, Heiken JP, et al. The abdominal compartment syndrome: CT findings. Am J Roentgenol,1999,173:575-579.
42. Hobson KG, Young KM, CirauloA, et al. Release of abdominal compartment syndrome improves survival in patients with burn injury. J Trauma,2002,53:1129-1133.
43. Meldrum DR, Moore FA, Moore FF, et al. Prospective characterization and selective management of the abdominal compartment syndrome. Am J Surg, 1997,174:667-673
44. Bruch JM, Moore EE, Moore FA, et al. The abdominal compartment syndrome. Surg Clin North Am,1996;76:833-842.
45. Gallagher JJ. How to recognize and manage abdominal compartment syndrome. Nurs Manage. 2004;Suppl:36-42.
46. Flores-Alvarez E, Avila-Cuevas GE, de la Torre-Gonzalez JC, Early diagnosis and risk factors associated with abdominal compartment syndrome. Cir Cir. 2005 May-Jun; 73(3):179-83.
47. Stagnitti F, Calderale SM, Priore F, et al. Ribaldi S,Abdominal compartment syndrome: patophysiologic and clinic remarks. G Chir. 2004 Oct;25(10):335-42.
48. Gonullu D, Ceylan A, Demiray O, et, al. The effect of selective bowel decontamination and mechanical bowel preparation on bacterial translocation due to intraabdominal hypertension Ulus Travma Derg. 2005 Jul;11(3):201-5.
49. Balogh Z, Moore FA. Intra-abdominal hypertension: not just a surgical critical care curiosity. Crit Care Med. 2005 Feb;33(2):447-9.
50. Oda J, Ueyama M, Yamashita K, et, al. Hypertonic lactated saline resuscitation reduces the risk of abdominal compartment syndrome in severely burned patients. J Trauma. 2006 Jan;60(1):64-71.
51. O'Mara MS, Slater H, Goldfarb IW, et, al. A prospective, randomized evaluation of intra-abdominal pressures with crystalloid and colloid resuscitation in burn patients. J Trauma. 2005 May;58(5):1011-8.
52. 吴咸中.中西医结合急腹症方药诊释.天津:天津科学技术出版社,2001.356 -358.
53. 汤耀卿,雷若庆.提高对重症胰腺炎合并腹腔间隔室综合征的认识.外科理论与实践,2001,6(6):361- 362.
54. 何泽民.重症胰腺炎致急性腹腔间隔室综合征 21 例报告. 实用临床医学,2004,5(4):59-61
55. 李志新,邱锦芳,张忠.通腑攻下法治疗重症急性胰腺炎合并腹腔间隔室综合征临床体会. 新中医,2004,36(10):33-34.
56. Wong K, Summerhays CF. Abdominal compartment syndrome: a new indication for operativeintervention in severe acute pancreatitis. Int J Clin Pract. 2005 Dec;59(12):1479-81.
57. Moore EE. Staged laparotomy for the hypothermia, acidosis and coagulopathy syndrome. Am J Surg, 1997, 174:667-673.
58. Martinez-Ordaz JL, Cruz-Olivo PA, Chacon-Moya,et al. Management of the abdominal wall in sepsis. Comparison of two techniques. Rev Gastroenterol Mex. 2004 Apr-Jun;69(2):88-93.
59. De Waele JJ, Hoste EA, Malbrain ML.Decompressive laparotomy for abdominal compartment syndrome - a critical analysis. Crit Care. 2006 Mar 27;10(2):R51 [Epub ahead of print]
60. Kopelman T, Harris C, Miller R, et al. Abdominal compartment syndrome in patients with isolated extraperitoneal injuries. J Trauma, 2000; 49(4):744
61. Burrows R, Edington J, Robbs JV. A wolf in wolf’ s clothing: the abdominal compartment syndrome. S Afr Med J,1995;85(1):46
62. Oda J, Ueyama M, Yamashita K,et,al. Effects of escharotomy as abdominal decompression on cardiopulmonary function and visceral perfusion in abdominal compartment syndrome with burn patients. J Trauma. 2005 Aug;59(2):369-74.
63. Dakin GF, Nahouraii R, Gentileschi P, et,al. Subcutaneous endoscopic fasciotomy in a porcine model of abdominal compartment syndrome: a feasibility study. J Laparoendosc Adv Surg Tech A. 2004 Dec;14(6):339-44.
64. Hinck D, Struve R, Gatzka F,et,al. Vacuum-Assisted Fascial Closure in the Management of Diffuse Peritonitis. Zentralbl Chir. 2006 Apr;131(S 1):108-110.
65. Martinez-Ordaz JL, Cruz-Olivo PA, Chacon-Moya E, et,al. Management of the abdominal wall in sepsis. Comparison of two techniques. Rev Gastroenterol Mex. 2004 Apr-Jun;69(2):88-93.
66. Letoublon C, Cardin N, Arvieux C. Laparostomy with vacuum pack technique. Ann Chir. 2005 Oct;130(9):587-9. Epub 2005 Sep 27.
67. Kendrick JE 4th, Leath CA 3rd, Melton SM, et,al Use of a fascial prosthesis for management of abdominal compartment syndrome secondary to obstetric hemorrhage. Obstet Gynecol. 2006 Feb;107(2 Pt 2):493-6.
68. Offner PJ, de Souza AL, Moore EE, et al. Avoidance of abdominal compartment syndrome in damage-control laparotomy after trauma .Arch Surg,2001;136(6):676.
69. Saenko VF, Belianskii LS, Lisun IuB. Modern approaches to the problem of temporary closure of the abdominal cavity. Klin Khir. 2005 Mar;(3):5-11.
70. Hultman CS, Pratt B, Cairns BA,et,al. Multidisciplinary approach to abdominal wall reconstruction after decompressive laparotomy for abdominal compartment syndrome. Ann Plast Surg. 2005 Mar;54(3):269-75; discussion 275.
71. Hultman CS, Pratt B, Cairns BA, et al. Multidisciplinary Approach to Abdominal Wall Reconstruction After Decompressive Laparotomy for Abdominal Compartment Syndrome. Ann Plast Surg. 2005 Mar;54(3):269-275.
1. Britt RC, Gannon T, Collins JN, et, al. Secondary abdominal compartment syndrome: risk factors and outcomes. Am Surg. 2005 Nov;71(11):982-5.
2. Hsu YP, Chen RJ, Fang JF, et,al. Increased susceptibility to oxidant injury in hepatocytes from rats with intra-abdominal hypertension. J Trauma. 2004 Sep;57(3):569-75.
3. Serpytis M, Ivaskevicius J. Intra-abdominal hypertension and multiple organ dysfunction syndrome. Medicina (Kaunas). 2005;41(11):903-9.
4. Espeel B, Gerard C, Nzamuche JR,et,al. Late abdominal compartment syndrome secondary to traumatic gallbladder rupture. Gastroenterol Clin Biol. 2005 Apr;29(4):453-5.
5. 程君涛,肖光夏,夏培元,等.腹内高压对兔肠道通透性及内毒素细菌移位的影响.中华烧伤杂志2003,19(4):229-232.
6. Lambert DM, Marceau S, Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg. 2005 Oct;15(9):1225-32.
7. Jensen AR, Hughes WB, Grewal H. Secondary Abdominal Compartment Syndrome in Children WithBurns and Trauma: A Potentially Lethal Complication. J Burn Care Res. 2006 March/April;27(2):242-246.
8. Britt RC, Gannon T, Collins JN, et, al. Secondary abdominal compartment syndrome: risk factors and outcomes. Am Surg. 2005 Nov;71(11):982-5.
9. Hsu YP, Chen RJ, Fang JF, et,al. Increased susceptibility to oxidant injury in hepatocytes from rats with intra-abdominal hypertension. J Trauma. 2004 Sep;57(3):569-75.
10. Ravishankar N, Hunter J.Measurement of intra-abdominal pressure in intensive care units in the United Kingdom: a national postal questionnaire study. Br J Anaesth. 2005 Jun;94(6):763-6. Epub 2005 Mar 11.
11. Balogh Z, Jones F, D'Amours S, et,al. Continuous intra-abdominal pressure measurement technique. Am J Surg. 2004 Dec;188(6):679-84.
12. Pickhardt PJ,Shimony JS, Heiken JP, et al. The abdominal compartment syndrome: CT findings. Am J Roentgenol,1999,173:575-579.
13. Hobson KG, Young KM, CirauloA, et al. Release of abdominal compartment syndrome improves survival in patients with burn injury. J Trauma,2002,53:1129-1133.
14. Meldrum DR, Moore FA, Moore FF, et al. Prospective characterization and selective management of the abdominal compartment syndrome. Am J Surg, 1997,174:667-673
15. Bruch JM, Moore EE, Moore FA, et al. The abdominal compartment syndrome. Surg Clin North Am,1996;76:833-842.
16. Kendrick JE 4th, Leath CA 3rd, Melton SM, et,al Use of a fascial prosthesis for management of abdominal compartment syndrome secondary to obstetric hemorrhage. Obstet Gynecol. 2006 Feb;107(2 Pt 2):493-6.
17. Offner PJ, de Souza AL, Moore EE, et al. Avoidance of abdominal compartment syndrome in damage-control laparotomy after trauma [J].Arch Surg,2001;136(6):676.
18. Saenko VF, Belianskii LS, Lisun IuB. Modern approaches to the problem of temporary closure of the abdominal cavity. Klin Khir. 2005 Mar;(3):5-11.
19. Hultman CS, Pratt B, Cairns BA,et,al. Multidisciplinary approach to abdominal wall reconstruction after decompressive laparotomy for abdominal compartment syndrome. Ann Plast Surg. 2005 Mar;54(3):269-75; discussion 275.
20. Hultman CS, Pratt B, Cairns BA, et al. Multidisciplinary Approach to Abdominal Wall Reconstruction After Decompressive Laparotomy for Abdominal Compartment Syndrome. Ann Plast Surg. 2005 Mar;54(3):269-275.
21. 汤耀卿,雷若庆.提高对重症胰腺炎合并腹腔间隔室综合征的认识.外科理论与实践,2001,6(6):361- 362.
22. 何泽民.重症胰腺炎致急性腹腔间隔室综合征 21 例报告. 实用临床医学,2004,5(4):59-61
23. 李志新,邱锦芳,张忠.通腑攻下法治疗重症急性胰腺炎合并腹腔间隔室综合征临床体会. 新中医,2004,36(10):33-34.
1. Gallagher JJ. How to recognize and manage abdominal compartment syndrome. Nurs Manage. 2004;Suppl:36-42.
2. Flores-Alvarez E, Avila-Cuevas GE, de la Torre-Gonzalez JC, Early diagnosis and risk factors associated with abdominal compartment syndrome. Cir Cir. 2005 May-Jun; 73(3):179-83.
3. Meldrum DR, Moore FA, Moore FF, et al. Prospective characterization and selective management of the abdominal compartment syndrome. Am J Surg, 1997,174:667-673
4. Stagnitti F, Calderale SM, Priore F, et al. Ribaldi S,Abdominal compartment syndrome: patophysiologic and clinic remarks. G Chir. 2004 Oct;25(10):335-42.
5. Wong K, Summerhays CF. Abdominal compartment syndrome: a new indication for operative intervention in severe acute pancreatitis. Int J Clin Pract. 2005 Dec;59(12):1479-81.
6. Moore EE. Staged laparotomy for the hypothermia, acidosis and coagulopathy syndrome. Am J Surg, 1997, 174:667-673.
7. Martinez-Ordaz JL, Cruz-Olivo PA, Chacon-Moya,et al. Management of the abdominal wall in sepsis. Comparison of two techniques. Rev Gastroenterol Mex. 2004 Apr-Jun;69(2):88-93.
8. De Waele JJ, Hoste EA, Malbrain ML.Decompressive laparotomy for abdominal compartment syndrome - a critical analysis. Crit Care. 2006 Mar 27;10(2):R51 [Epub ahead of print]
9. Kopelman T, Harris C, Miller R, et al. Abdominal compartment syndrome in patients with isolated extraperitoneal injuries[J]. J Trauma, 2000; 49(4):744
10. Burrows R, Edington J, Robbs JV. A wolf in wolf’ s clothing: the abdominal compartment syndrome[J]. S Afr Med J,1995;85(1):46
11. Oda J, Ueyama M, Yamashita K,et,al. Effects of escharotomy as abdominal decompression on cardiopulmonary function and visceral perfusion in abdominal compartment syndrome with burn patients. J Trauma. 2005 Aug;59(2):369-74.
12. Chen RJ , Fang JF , Chen MF. Intra-abdominal pressure monitoring as a guideline in thenonoperative management of blunt hepatic trauma [J]. J Trauma, 2001; 51 (1): 44.
13. Dakin GF, Nahouraii R, Gentileschi P, et,al. Subcutaneous endoscopic fasciotomy in a porcine model of abdominal compartment syndrome: a feasibility study. J Laparoendosc Adv Surg Tech A. 2004 Dec;14(6):339-44.
14. Hinck D, Struve R, Gatzka F,et,al. Vacuum-Assisted Fascial Closure in the Management of Diffuse Peritonitis. Zentralbl Chir. 2006 Apr;131(S 1):108-110.
15. Martinez-Ordaz JL, Cruz-Olivo PA, Chacon-Moya E, et,al. Management of the abdominal wall in sepsis. Comparison of two techniques. Rev Gastroenterol Mex. 2004 Apr-Jun;69(2):88-93.
16. Letoublon C, Cardin N, Arvieux C. Laparostomy with vacuum pack technique. Ann Chir. 2005 Oct;130(9):587-9. Epub 2005 Sep 27.
17. Kendrick JE 4th, Leath CA 3rd, Melton SM, et,al Use of a fascial prosthesis for management of abdominal compartment syndrome secondary to obstetric hemorrhage. Obstet Gynecol. 2006 Feb;107(2 Pt 2):493-6.
18. Offner PJ, de Souza AL, Moore EE, et al. Avoidance of abdominal compartment syndrome in damage-control laparotomy after trauma [J].Arch Surg,2001;136(6):676.
19. Saenko VF, Belianskii LS, Lisun IuB. Modern approaches to the problem of temporary closure of the abdominal cavity. Klin Khir. 2005 Mar;(3):5-11.
20. Hultman CS, Pratt B, Cairns BA,et,al. Multidisciplinary approach to abdominal wall reconstruction after decompressive laparotomy for abdominal compartment syndrome. Ann Plast Surg. 2005 Mar;54(3):269-75; discussion 275.
21. Hultman CS, Pratt B, Cairns BA, et al. Multidisciplinary Approach to Abdominal Wall Reconstruction After Decompressive Laparotomy for Abdominal Compartment Syndrome. Ann Plast Surg. 2005 Mar;54(3):269-275.
22. Gonullu D, Ceylan A, Demiray O, et, al. The effect of selective bowel decontamination and mechanical bowel preparation on bacterial translocation due to intraabdominal hypertension Ulus Travma Derg. 2005 Jul;11(3):201-5.
23. Balogh Z, Moore FA. Intra-abdominal hypertension: not just a surgical critical care curiosity. Crit Care Med. 2005 Feb;33(2):447-9.
24. Oda J, Ueyama M, Yamashita K, et, al. Hypertonic lactated saline resuscitation reduces the risk of abdominal compartment syndrome in severely burned patients. J Trauma. 2006 Jan;60(1):64-71.
25. O'Mara MS, Slater H, Goldfarb IW, et, al. A prospective, randomized evaluation of intra-abdominal pressures with crystalloid and colloid resuscitation in burn patients. J Trauma. 2005 May;58(5):1011-8.
26. 吴咸中.中西医结合急腹症方药诊释.天津:天津科学技术出版社,2001.356 -358.
27. 汤耀卿,雷若庆.提高对重症胰腺炎合并腹腔间隔室综合征的认识.外科理论与实践,2001,6(6):361- 362.
28. 何泽民.重症胰腺炎致急性腹腔间隔室综合征 21 例报告. 实用临床医学,2004,5(4):59-61
29. 李志新,邱锦芳,张忠.通腑攻下法治疗重症急性胰腺炎合并腹腔间隔室综合征临床体会. 新中医,2004,36(10):33-34.
1. Hsu YP, Chen RJ, Fang JF, et,al. Increased susceptibility to oxidant injury in hepatocytes from rats with intra-abdominal hypertension. J Trauma. 2004 Sep;57(3):569-75.
2. Serpytis M, Ivaskevicius J. Intra-abdominal hypertension and multiple organ dysfunction syndrome. Medicina (Kaunas). 2005;41(11):903-9.
3. Shiiya N, Matsuzaki K, Miyatake T, et,al. Abdominal compartment syndrome causing respiratory failure during surgery for a ruptured descending thoracic aneurysm: report of a case. Surg Today. 2005;35(4):320-2.
4. Simon RJ, Friedlander MH,Ivatury RR,et al. Hemorrhage lower thethreshold for intra-abdominal hypertension(IAH) induced pulmonary dysfunction[J].J Trauma,1997;42(3):398
5. Stagnitti F, Calderale SM, Priore F, et,al. Abdominal compartment syndrome: patophysiologic and clinic remarks. G Chir. 2004 Oct;25(10):335-42.
6. Bloomfield GL,Blocher CR,Fakhry IF,et al. Elevated intra-abdominal pressure Increases plasma rennin activity and aldosterone levels[J].J Trauma,1997;42(6):997
7. Ma YM, Qian C, Xie F, et,al. Acute renal failure due to abdominal compartment syndrome. Zhonghua Yi Xue Za Zhi. 2005 Aug 17;85(31):2218-20.
8. de Jong IJ, Veeken H, van der Heide K, Clinical reasoning and decision-making in practice. A patient with oliguria following prostatectomyNed Tijdschr Geneeskd. 2005 Dec 3;149(49):2720-7.
9. Diebel LN , Dulchavsky SA, Brown WJ. Splanchnic ischemia and bacterial translocation in the abdominal compartment syndrome[J]. J Trauma , 1997 ; 43 (5): 852
10. Bloomfield GL, Ridings PC, Blocher CR, et al. Aproposed relationship between increasedintra-abdominal, intrathoracic, and intracranial pressure[J].Crit Care Med,1997;25(3):496
11. Bloomfield GL,Dalton JM,Sugerman HJ,et al.Treatment of increasing intracranial pressure secondary to the acute abdominal compartment syndrome in a patient with combined abdominal and head trauma[J].J Trauma,1995;39(6):1168
12. Pirson J, Zizi M, Jacob E, et,al. Acute ischemic optic neuropathy associated with an abdominal compartment syndrome in a burn patient. Burns. 2004 Aug;30(5):491-4.
13. Kutayli ZN, Domingo CB, Steinberg SM. Intestinal failure. Curr Opin Anaesthesiol. 2005 Apr;18(2):123-7.
14. Yagci G, Zeybek N, Kaymakcioglu N,et,al. Increased intra-abdominal pressure causes bacterial translocation in rabbits. J Chin Med Assoc. 2005 Apr;68(4):172-7.
15. 程君涛,肖光夏,夏培元,等.腹内高压对兔肠道通透性及内毒素细菌移位的影响.中华烧伤杂志2003,19(4):229-232.
1. 李乃卿.重新认识胃肠道,中华中西医临床杂志,2004,4(7):773-774.
2. Wilmore DW. The gut: a central organ after surgical stress. Surgery. 1988,104:917.
3. 黎介寿.肠衰竭-概念、营养支持与肠黏膜屏障维护. 肠外与肠内营养,2004,11(2):65-67.
4. Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin. 2005 Apr;21(2):177-96. Review.
5. Deitch EA, Xu D, Kaise VL. Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci. 2006 Jan 1;11:520-8.
6. 陈秀凯,蒲践一,邱方,等.二胺氧化酶与 D-乳酸对脑损伤大鼠肠屏障功能的监测意义.中国煤炭工业医学杂志,2003,6(7): 669-671.
7. 姚咏明,盛志勇,吴叶,等.大鼠急性肠缺血后 D-乳酸的变化及其与肠黏膜损害的关系[J].中华烧伤整形外科杂志,1998,4(4):266-269.
8. 孙晓庆,付小兵,张蓉,等.创伤后肠道通透性改变血浆标志物 D-乳酸的实验研究.中国危重病急救医学,2000,12(8)476-478.
9. 程君涛,肖光夏,夏培元,等.腹内高压对兔肠道通透性及内毒素细菌移位的影响.中华烧伤杂志,2003,19(4): 229-232
10. Margaritis VG, Filos KS, Michalaki MA, et al. Effect of oral glutamine administration on bacterial tanslocation, endotoxemia, liver and ileal morphology, and apoptosis in rats with obstructive jaundice. World J Surg. 2005 Oct;29(10):1329-34.
11. Domeneghini C, Di Giancamillo A, Bosi G, et al. Can nutraceuticals affect the structure of intestinal mucosa? Qualitative and quantitative microanatomy in L-glutamine diet-supplemented weaning piglets.Vet Res Commun. 2006 Apr;30(3):331-42.
12. Coeffier M, Dechelotte P. The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome.Nutr Rev. 2005 Feb;63(2):65-9.
13. Hulsewe KW, van der Hulst RW, et al. Inflammation rather than nutritional depletion determines glutamine concentrations and intestinal permeability. Clin Nutr. 2004 Oct;23(5):1209-16.
14. 曹建春,张东萍,李乃卿.肠源性 MODS 的发生机制.医学研究杂志, 2006,35(2):56-57.
15. 张亚瑞,唐方. 中医药对肠屏障功能保护作用的研究概况.浙江中医杂志,2005,(3):133-135.
16. 刘蓉,唐方.中药保护肠屏障功能研究概况. 上海中医药杂志,2004, 38(12):57-59.
17. 张子理,陈蔚文.党参、黄芪、白术、甘草提取部位对小肠上皮细胞增殖的影响.中药药理与临床,2002,18(1):10-12.
18. 张 子 理 , 陈 蔚 文 . 黄 芪 注 射 液 和 白 术 提 取 部 位 对 小 肠 上 皮 细 胞 移 行 的 影 响 . 中 草药,2002,33(10):912-915.
19. 吴承堂,黎沾良.中药清胰汤对犬急性坏死性胰腺炎肠黏膜损伤修复的影响.中国普外基础与临床杂志,1998,5(6):326-328.
20. 姚永莉,宋于刚,张万岱.四君子汤治疗实验脾虚证对胃肠黏膜细胞增殖动力学的影响[J].世界华人消化杂志,1999,7(6):550.
21. 张建平,许利剑,徐凛峰,等.银杏叶提取物对大鼠实验性重症胰腺炎肠黏膜屏障功能的影响.江苏医药,2004,30(1): 18-20.
22. 王孟清,欧正武,吴明侦,等.健运冲剂促脾虚泄泻模型大鼠受损肠黏膜修复的研究[J].中国中西医结合脾胃杂志,1999,7(4):217-219.
23. 谢肄聪,唐方.藿香正气软胶囊对肠屏障功能保护作用的实验研究.中草药,2003,34(3):252-254.
24. 邱 奇,崔乃强,吴咸中.大承气冲剂对腹腔感染所致 SIRS/MODS 的治疗作用. 中国中西医结合外科杂志,2004, 10(4): 239-243.
25. 陈海龙,吴咸中,关凤林,等.中医攻里通下法对多脏器功能不全征时肠道屏障功能保护作用的实验研究.中国中西医结合杂志,2000,20(2):120.
26. 陈德昌,杨建东,景炳文,等.大黄对大鼠肠黏膜及肠血管通透性的影响. 中国危重病急救医学,1997,9(7):385-387.
27. 解基良,张志尧,吴咸中.承气方剂对肠屏障功能保护作用的实验研究. 中国中西医结合外科杂志.2002,8(3):189-191.
28. 倪孝儒,李雪蕾,曹建春.通腑汤高位直肠滴入治疗重症急性胰腺炎 46 例临床观察,中华中西医临床杂志,2004;4(7):814-815.
29. 邓轶,陈航,崔朝阳,等. 通腑汤保留灌肠治疗急性胰腺炎 45 例,北京中医药大学学报,2000,
23:59-61
30. 孙欣,李乃卿.经肛肠途径营养支持的可行性探讨,中华中西医临床杂志,2003,3(6):683-
689
31. 李乃卿.高位直肠滴入通腑汤的疗效观察。北京中医,1992,33(4):56-57.
32. 滕占庆,李乃卿。通腑汤调理胃肠道功能的疗效观察,中国中西医结合外科杂志,1997,3:102-104.
33. 倪孝儒,李乃卿,李雪蕾,等.通腑汤直肠高位滴注的临床研究,北京中医药大学学报,2000;23(2):61-63.
34. 席军生,曹建春.肠源性 MODS. 中华实用中西医杂志,2005, 18(23): 1868-1869
35. 黄棉生,刘东举,庄业忠,等.针刺保护胃肠道肿瘤术后 TPN 过程肠黏膜屏障损害的临床研究.中国肿瘤临床与康复,2002,9(1):40.
36. 康复笑,韩宜印,何淑贤,等.生大黄促进术后胃肠功能恢复的临床观察.中国中西医结合外科杂志,2002,8(3):168
37. 夏中元,罗涛,夏芳,等.生脉注射液对肠黏膜再灌注损伤保护作用机制的实验研究[J].中华麻醉学杂志,2001,21(5):299-301.
38. 陈少夫,贺丽,周卓,等.党参对兔胃十二指肠黏膜中胃泌素 生长抑素的影响[J].中国医科大学学报,2002,31(3):164-165.
39. 王 万 铁 , 徐 正 , 林 丽 娜 , 等 . 川 芎 嗪 对 肠 黏 膜 屏 障 功 能 的 保 护 作 用 . 中 国 病 理 生 理 杂 志 2001,17(9):882-885.
40. 黑子清,林世清,刘卫峰,等.黄茂对失血性休克再灌注兔肠黏膜微循环血流量的影响.中华麻醉学杂志,2003,23(7): 543-544.
41. 刘 承 哲 , 刘 牧 林 . 大 黄 对 多 器 官 衰 竭 大 鼠 肠 黏 膜 屏 障 的 保 护 作 用 [J]. 蚌 埠 医 学 院 学报,1998,23(6):380-381.
42. 黄兴兰,陈晓理,贾成瑶,等.大黄对 Balb/c 小鼠肠黏膜屏障保护作用的机理探讨[J].四川医学,1999,20(5):486-487.
43. 赵卫川,崔乃强,赵琪.承气合剂对缺血再灌流肠管内毒素转运的影响[J].中国中西医结合外科杂志,1998,4(2):83-86.
44. 陈海龙,冯立民,关凤林.阳明腑实证患者肠黏膜屏障功能的改变及复方大承气汤干预作用的临床观察[J].中医杂志,2003,44(9):672-673.
45. 李钢,陈海平,王凯成,等.中药合剂 AA3 保护实验性急性胰腺炎大鼠肠黏膜屏障的研究. 中国危重病急救医学,1999,11(5): 273-275.
46. 尤家平,蒋道国,李广元.芪连液保留灌肠治疗婴幼儿秋季腹泻临床与实验研究.中国中西医结合杂志,2000,20(9):664.
47. 张晓峰,苏佩清,任建素,等.中药清肠栓对溃疡性结肠炎大鼠实验模型的影响.河北医学,1998,4(5):1
48. 次秀丽,王宝恩,张淑文,等.肿瘤坏死因子和内毒素致大鼠肠黏膜屏障损伤的中药治疗研究.中国危重病急救医学,1999,11(5):262.
49. 宋路线,徐迎新,宋旭华,等.大黄煎剂延迟并下调肠道相关淋巴细胞凋亡.实用医学杂志,2000,16(7):530.
50. 曹建春,李乃卿.肠源性 MODS 研究现状.中华中西医临床杂志,2005,5(12):912-916.
1. Karime R,Matsumoto S,Higashi H et al . The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today,1999,5 (8) :123-132.
2. Perti P,Mazzei T. Antibiotic2induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock : a review. J Chemother,1998,10 (5) : 427-448.
3. 田牛,主编. 微循环方法学. 北京: 原子能出版社,1993. 12,1-233.
4. Song Y,Shen H. Protective effect of naloxone on rat cortical neuron induced by hypoxia. Chin J Emerg Med,2004,13 (3) : 155-157.
5. 川崎博已.肠系膜微循环与血管周围神经性调节.日本医学介绍,2002,23(11): 504-505
6. Cohen J.The detection and interpretation of endotoxaemia. Intesive Care Med,2000,26(suppl): 51-56.
7. 符庆瑛,李著华,张艳青,等.PGI2 对肾缺血再灌损伤兔肠系膜微循环和血液流变性的影响.中国病理生理杂志,2005 ,21(2) :361 - 366
8. 张钢, 高钰琪, 刘福玉. 急性缺氧对大鼠肠系膜微循环白细胞流变学行为的影响. 第三军医大学学报,2002,24(3) : 320 - 322.
9. Yokoyama C , Yebuki T, Shimonishi M, et al. Prostacyclin-deficient mice develop ischemic renal disorders , including nephrosclerosis and renal infarction [ J ] . Circulation , 2002 ,106 (18) : 2397 - 2403.
10. Fujita T, Fuke Y, Satomura A , et al. PGI2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency [ J ] . Prostaglandins Leukot Essent Fatty Acids , 2001 , 65(4) : 223 - 227.
11. 丁库克, 曾衍钧, 廖东华,等. 脑缺血及再灌注对血液粘度与红细胞变形性的影响. 首都医科大学学报,2001 , 22(1) : 6 - 9.
12. Habon T, Szabados E , Kesmarky G, et al. The effect of carvedilol on enhanced ADP - ribosylation and red blood cell membrane damage caused by free radicals. Cardiovasc Res.2001.52(1) :153 -160.
13. Kozek - Langenecker SA , Spiss CK, Michalek - Sauberer A , et al. Effect of prostacyclin on platlets , polymorphonuclear cell , and heterotypic cell aggregation during hemofiltration[J ] .Crit Care Med , 2003 , 31(3) : 864 - 868.
14. 王怡, 王仰宗. 实用临床血液流变学[M] . 北京: 学苑出版社, 1994. 41 - 41.
15. Jahr J , Ekelund U , Grande PO. In vivo effects of prostacyclin on segmental vascular resistances ,on myogenic reactivity ,and on capillary fluid exchange in cat skeletal muscle [ J ] . Crit Care Med , 1995 , 23(3) : 523 - 531.
16. 宋益民,李学坤,谭建民,等.阿司匹林、维拉帕米单用和合用对大鼠肠系膜微循环的影响.中国临床药理学与治疗学, 2001 ;6(1): 31-34
17. 千智斌,姬明丽.急性右心衰竭兔中心静脉压及颈总动脉压与肠系膜微循环的关系.新乡医学院学报,2001,18(2 ):88-90
18. 宋康兴,沈洪,朱海燕,等.纳洛酮对内毒素血症大鼠肠系膜微循环变化的影响.中华急诊医学杂志,2005,14 (5):391-393
19. 王柏生. 临床血液流变学[M] . 第 1 版. 郑州: 河南医科大学出版社, 1999. 76 - 77.
1. Bruch JM, Moore EE, Moore FA, et al. The abdominal compartment syndrome. Surg Clin North Am,1996;76:833-842.
2. 李乃卿主编.中西医结合外科学.北京:中国中医药出版社,2005,第 1 版:213-216
3. 解基良,张志尧,吴咸中.承气方剂对肠屏障功能保护作用的实验研究. 中国中西医结合外科杂志.2002,8(3):189-191.
4. 倪孝儒,李雪蕾,曹建春.通腑汤高位直肠滴入治疗重症急性胰腺炎 46 例临床观察,中华中西医临床杂志,2004;4(7):814-815.
5. 邓轶,陈航,崔朝阳,等. 通腑汤保留灌肠治疗急性胰腺炎 45 例,北京中医药大学学报,2000,23:59-61
6. 孙欣,李乃卿.经肛肠途径营养支持的可行性探讨,中华中西医临床杂志,2003,3(6):683-689
7. 李乃卿.高位直肠滴入通腑汤的疗效观察。北京中医,1992,33(4):56-57.
8. 滕占庆,李乃卿。通腑汤调理胃肠道功能的疗效观察,中国中西医结合外科杂志,1997,3:102-104.
9. 倪孝儒,李乃卿,李雪蕾,等.通腑汤直肠高位滴注的临床研究,北京中医药大学学报,2000;23(2):61-63.
10. 曹建春,李乃卿.肠源性 MODS 研究现状.中华中西医临床杂志,2005,5(12):912-916.
11. 刘 承 哲 , 刘 牧 林 . 大 黄 对 多 器 官 衰 竭 大 鼠 肠 黏 膜 屏 障 的 保 护 作 用 [J]. 蚌 埠 医 学 院 学报,1998,23(6):380-381.
12. 黄兴兰,陈晓理,贾成瑶,等.大黄对 Balb/c 小鼠肠黏膜屏障保护作用的机理探讨[J].四川医学,1999,20(5):486-487.
13. 赵卫川,崔乃强,赵琪.承气合剂对缺血再灌流肠管内毒素转运的影响[J].中国中西医结合外科杂志,1998,4(2):83-86.
14. 陈海龙,冯立民,关凤林.阳明腑实证患者肠黏膜屏障功能的改变及复方大承气汤干预作用的临床观察.中医杂志,2003,44(9):672-673.
15. 吴承堂,黎沾良.中药清胰汤对犬急性坏死性胰腺炎肠黏膜损伤修复的影响.中国普外基础与临床杂志,1998,5(6):326-328.
16. 李钢,陈海平,王凯成,等.中药合剂 AA3 保护实验性急性胰腺炎大鼠肠黏膜屏障的研究. 中国危重病急救医学,1999,11(5): 273-275.
17. 康复笑,韩宜印,何淑贤,等.生大黄促进术后胃肠功能恢复的临床观察.中国中西医结合外科杂志,2002,8(3):168
18. 陈德昌,杨建东,景炳文,等.大黄对大鼠肠黏膜及肠血管通透性的影响. 中国危重病急救医学,1997,9(7):385-387.
19. 席军生,曹建春.肠源性 MODS. 中华实用中西医杂志,2005,18(23):1868-1869
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |